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SUMMARY 
 
Metals are major environmental pollutants due to the long periods of use (in case of lead, from ca. 
3500 BC on) and the immense amounts produced. Many metals are xenobiotics because they used to 
have minimal presence (and, hence, bioavailability) before man-made emission into the environment 
had begun, and because they either are completely useless and toxic for the human organism (e.g. 
mercury, lead or cadmium) or are essential micronutrients but toxic when overdosed (manganese, 
chromium, copper, etc.). 
Metal-containing dusts and fumes are generated along the complete life cycle of metal articles and 
are found in the workplace atmosphere. Airborne metals cause primarily inhalational exposure, the 
extent of which is influenced by the chemical form of the metals and the particle size. Environmental 
nanoparticles (NPs) have important health effects on their own. Their submicroscopic size and large 
specific surface area, together with the high numbers of NPs entering the organism in a typical 
exposure situation, result in great biological activity. Metal ions dissolved from the surface of NPs 
also must be considered among the mechanisms of action. 
The second most important route of exposure to heavy metals is probably ingestion. Dust can 
contaminate food or drink. Further, incorporation and accumulation of toxic metals from the soil is 
characteristic for numerous plants, including ones used for staple food production, the case cadmium 
content in rice being an example. 
Regarding the multitude of applications of metals, the broad spectrum of heavy metal toxicity and its 
consequences, as well as the modes of their possible entrance into the organism, it is of paramount 
importance study this problem further on, among others by animal experiments based on more and 
more adequate models. Based on practical importance and on previous experiences of the 
Department, lead, cadmium and manganese were chosen for the work subserving this thesis. 
 
Lead (Pb) has been a ubiquitous environmental pollutant, and is toxic even in low doses. 
Primary production and reprocessing of Pb is based on smelting, with substantial emission of 
metal fumes. Airborne Pb causes significant internal exposure both in humans and in 
experimental animals, and the harms of Pb ingested with contaminated food is well-known. 
Its human nervous systems effects include encephalopathy, diminished learning ability and 
behavioral problems in children. In adults occupationally exposed to Pb, alterations of various 
forms of central and peripheral evoked activity were described. 
Cadmium, used for industrial purposes (electroplating, batteries, pigments, alloys etc.) is one 
of the most toxic environmental pollutants; damaging the lungs, liver, kidney, testis, brain etc. 
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Significant inhalation of Cd can occur from tobacco smoke and in occupational settings. 
Cereals, especially rice, also tend to accumulate Cd from the soil, resulting in foodborne 
exposure. Amyotrophic lateral sclerosis, optic nerve damage, striatal damage and peripheral 
polyneuropathy were observed as long term neurotoxic consequences. In children, a straight 
relationship between hair Cd and altered visual or auditory evoked potential parameters was 
found. 
Manganese (Mn) is, in contrast to lead and cadmium, an essential micronutrient, e.g. as cofactor in 
metallo-enzymes. It is used in many important alloys, so welding fumes and similar industrial 
emissions are a source of Mn-containing NPs. Chronic inhalation of manganese compounds causes 
severe neurologic disorders; starting with apathy, asthenia and headache, and ending in a Parkinson-
like syndrome. Oral or parenteral overdosing of Mn can induce the same symptoms. Disorders with 
electrophysiological signs after Mn exposure include e.g. myoclonus in welders and epileptic activity 
in an accidentally exposed child.  
 
In previous experiments it was found that recording and analysis of central and peripheral 
electrophysiological signals, and of certain behavioral phenomena, is sufficiently sensitive to detect 
the effects of lead, cadmium and manganese on the nervous system of rats, applied subacutely in 
dissolved form orally, or in the form of nanoparticles by intratracheal instillation. In order to obtain a 
more adequate model, these two forms of metal application were combined in the present work to 
imitate exposure coming both from environmental (food/waterborne) and occupational 
(inhalational) sources. 
 
The aims of the work were specified in the following questions: 
• Are the treatment schemes and doses used previously for application of manganese, lead and 
cadmium in dissolved form orally, and in nanoparticulate form intratracheally, usable also in 
combination exposure? 
• What quantitative and qualitative differences can be observed in the general toxicological, 
electrophysiological and behavioral changes obtained by applying the mentioned metals only 
in dissolved oral form, only in nanoparticulate intratracheal form, , and in combining these 
forms of application? 
• Is the dose-response relationship in oral-only, intratracheal-only, and combined application 
different? 
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Experimental work was done on young adult male Wistar rats. The three metals were 
administered to the rats (10 animals per group) in two physicochemical forms and two ways. 
Aqueous solution was given orally by gavage (per os, po.), while the suspension of NP form 
was instilled in the trachea (intratracheally, it.). The chemical identity and dose of the 
substances applied to the rats was as follows: 
 
Metal Compound Doses (mg/kg b.w.) 
Manganese   
  dissolved form MnCl2⋅4H2O 15, 60 
  nanoparticulate form MnO2  (Ø 30.9±9.91nm) 2.63 
Cadmium   
  dissolved form CdCl2⋅2.5H2O 3.5 
  nanoparticulate form CdO2  (Ø 65.6±12.4 nm) 0.04 
Lead   
  dissolved form Pb(CH3COO)2⋅3H2O 80, 320 
  nanoparticulate form PbO  (Ø 38.9±7.20 nm) 2 
 
The doses were based on previous experience. For po. application, the compounds were dissolved in 
distilled water to 1 ml/kg b.w. administration volume and were given by gavage. The NPs were 
synthesized at the Department of Applied Chemistry, University of Szeged Faculty of Science and 
Informatics. For it. administration, the NPs were suspended in 1% hydroxyethyl cellulose (HEC) 
dissolved in PBS (pH 7.4), and instilled in the trachea of rats under brief diethyl ether anesthesia. 
The po. doses were given once daily, 5 days per week, for 3 and 6 weeks (Mn and Pb) or for 3 weeks 
(Cd). One half of the rats underwent then the behavioral and electrophysiological investigation 
described below while the others had subsequent it. administration of NPs, again for 3 and 6 weeks 
(Mn and Pb) or for 1 week (Cd). There was another Cd- treated group receiving NPs first. For each 
treatment variation, untreated and vehicle-treated controls were also made. Cd treatment 
necessitated a different scheme because of too high general toxicity. 
At the end of the treatment period, the rats’ spontaneous locomotor activity was measured in 
an open field (OF) box. The instrument recorded their horizontal and vertical movements (in 
one 10 min session per rat). Counts, time and run length of the activity forms (ambulation, 
local activity, immobility, rearing) were automatically calculated. 
The next day, the animals were anaesthetized by urethane. The left hemisphere was exposed, and 
ball-tipped silver recording electrodes were positioned on the dura over the primary somatosensory 
(SS) area (projection of the whisker pad), and over the primary visual (VIS) and auditory (AUD) area. 
One session consisted of six minutes recording of spontaneous activity (electrocorticogram, ECoG) 
first, from the three sensory cortical areas simultaneously. Then, evoked potentials (EPs) from the 
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same cortical areas were recorded, and finally the compound action potential of the tail nerve. SS 
stimulation was done by a pair of needles inserted into the whisker pad, delivering square electric 
pulses. VIS stimulation was performed by flashes, and AUD stimulation by sound clicks. Compound 
action potential of the tail nerve was evoked by means of a pair of stimulating needle electrodes 
inserted at the base of tail, and recorded by another pair of needles 50 mm distally. 
 
Body weight gain was reduced by all three metals. With Mn and Cd, the effect of the NP form 
on body weight gain was disproportionately strong, regarding the dose applied, much stronger 
than the effect of the dissolved form and also stronger than that of the NP form given alone in 
previous experiments. The relative weight of the liver (on the basis of brain weight) was 
decreased by the NP form of Mn and by both forms of Cd. Lung weight was massively 
increased by it. application of each metal. In the OF test, ambulation and rearing was 
decreased by Mn, and the changes were stronger after 6+6 (po., then it.) than after 6 weeks 
treatment. The Pb-treated rats showed more overall time and longer periods of ambulation, 
but less rearing. Also Cd caused reduced OF motility, most efficiently in the po.+it. scheme. 
In the ECoG, 6 weeks of po. Mm application caused a shift to higher frequencies. This change 
was not mad more intense by subsequent it. application. Orally applied Pb increased the slow 
and decreased the fast waves in the ECoG but in rats with po.+it. application this change was 
no more observed. Cd had no significant effect on the spontaneous cortical activity. 
The cortical EPs generally showed latency lengthening on the effect of the metals. Pb also 
caused increased extra lengthening of the latency on higher frequency stimulation (10 vs. 1 
Hz). It was conspicuous that the effect on the SS and VIS EP latency of Mn and Pb was about 
as strong after 3 weeks po. plus 3 weeks it. as after 6 weeks po. administration, although the 
summed dose was much lower in the former case. 
The conduction velocity of the tail nerve was decreased by Mn, Pb and Cd, and the relative 
refractory period increased by Mn and Cd. The anomalous dose dependence seen on the EP 
latency was present also on the nerve conduction velocity in case of Mn. 
 
Changes observed during the experiments described in this thesis suggested on several 
instances that there can be a more-than-additive interaction between the amounts of heavy 
metals given by po. and it. application. This can be due to the blood-brain barrier weakened 
by the op. given metal, being less able to exclude NPs, but the extreme mobility of NPs itself 
can result in higher metal levels in the CNS. The role of oxidative stress induced by the 
metals ond/or the NPs containing them must also be considered, and is one of the likely 
common mechanisms explaining the similar character of alteration induced by the three 
metals studied. Further such mechanisms are interference with Ca-dependent phenomena and 
with mitochondrial energy production.  
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Based on the results described and evaluated above, it can be stated that the attempt to model 
the complex exposure, coming both from environmental (food/waterborne) and occupational 
(inhalational) sources, was successful. And, investigation of general and nervous system 
effects of toxic environmental heavy metals in a combined exposure (dissolved form po. plus 
NP form it.) by means of a set of neuro-functional tests is apparently a model to which no 
direct parallel was found in the literature. 
Having in mind the presence of xenobiotic heavy metals in the (occupational and residential) 
environment and in commodities of environmental origin (drinking water and food) the health 
effects in general, and in particular the effects on sensitive systems like the nervous system, 
are of primary concern. The occurrence of metals in nanoparticulate form, adds a new feature 
to the old problem. 
 
The questions listed above can finally be answered as follows: 
• The treatment schemes and doses used previously for oral and intratracheal application could 
be adapted without significant change in case of Mn and Pb treatment. In case of Cd, strong 
general toxicity required the development of a new scheme with shorter it. exposures. The 
doses, although caused comparable alterations in the electrophysiological (and partly in the 
behavioral) parameters, were at the systemic level not “equitoxic”. 
• In quantitative aspect it became clear that the NP form of the metals, applied after weeks of 
oral exposure to the dissolved form, had disproportionately strong effect on the body weight 
gain (Mn, Cd) and on some of the open field behavioral parameters and on parameters of 
evoked electrophysiological responses (all three metals). Qualitative difference was seen 
mainly in the electrocorticograms, which possibly reflected the interference of NP-specific 
(oxidative stress) and metal-specific (altered synaptic transmission etc.) actions. Comparison 
with earlier intratracheal-only results also indicated that lower NP dose was enough to evoke 
the same effects when applied after oral treatment. 
• The differences in dose-response relationship could be examined only in terms of the external 
dose. Measurements of internal dose (tissue metal levels) constitute the necessary next step 
of the studies. In case of or al application of the metals in aqueous solution, thee effects 
were of similar kind and magnitude as seen earlier. It was known from the preceding 
intratracheal NP exposures that in this form much lower per kg doses are sufficient in terms 
of internal dose and functional effects. Comparison of the results from the present study to 
those mentioned above indicated that a lower NP dose was enough to evoke the same 
effects when applied after oral treatment. 
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1. INTRODUCTION 
 
1.1. General properties of metals. Heavy metals in history and human culture 
 
The majority of the chemical elements belong to the metals. Metals have good heat and 
electric conductivity, metallic shine, and more or less plastic deformability. Most metals are 
solid at room temperature. Electric conductivity and shine are due to the loosely bound 
electrons on the outer shell of metal atoms which are easily delocalized. These electrons are 
also lost in chemical reactions so that metals themselves are typically oxidized while reducing 
the other reacting substance. Metal atoms with more than one oxidation state, e.g. iron and 
manganese, tend to be involved in redox interactions which, under protoplasmic conditions, 
may result in the generation of oxidative free radicals. To achieve octet state, numerous metal 
atoms tend to form coordinate bonds with partners having a lone electron pair. Of the 
complexes and chelates formed this way, many – e.g. metallothioneins – fulfil biological 
functions. 
It is customary to group metals into light and heavy ones. This was originally based on 
density, and those with a density over 5 g/cm3 were regarded as heavy metals, but this 
categorization has been oft times superseded by other aspects including toxicity, resulting in 
confusion (Duffus, 2002). 
When prehistoric peoples started to use metals, it meant an unprecedented impact not only on 
technological development and life circumstances but also on the environment and their own 
health. Stone Age lasted until 4000 BC, when the use of copper (the first metal to be utilized 
by mankind) appeared and the cooper era began. Copper can be found in the nature, although 
rarely, in “native form” so using copper did not absolutely require the use of fire. All other 
metals are, however, found only in their ores, in form of compounds formed with oxygen, 
sulfur or other elements. Obtaining these metals required smelting them from the ores in fire, 
which was on one hand a substantial technical achievement but on the other hand a source of 
human exposure and environmental pollution. The exploitation of lead ore steadily increased 
in the antiquity, and at the Roman Empire’s heyday, lead production reached 80,000 
tons/year. The symptoms – loss of appetite, fatigue, lead colic, irritability, nervous spasm – 
seen in lead-mine workers were documented by Hippocrates and are described the same way 
even today. The environmental effects were not recognized in those times but the emissions 
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from ancient mines and smelters can today be identified (Breitenlechner et al., 2010; 
Thevenon et al., 2011). 
Around 3500 BC, lead was discovered, and around 3000 BC, tin. Tin and copper were melted 
together to bronze so that the period between 3000 BC and 800 BC is called the Bronze Age. 
Finally, in ca. 800 BC, iron was discovered and the list of metals with major practical 
applications was complete for centuries. Lead and its compounds were widely used in 
cosmetics, for preserving foodstuffs, or to prevent fermentation of the wine. Lead-containing 
alloys were made to “tin” cups, plates, pots and coins. This would be inconceivable today, for 
the known toxicity, but the human health effect was not obvious at that time and the “food-
preserving” effect of metal kitchenware, due to the antimicrobial action of the dissolved 
metals, was appreciated. Romans e.g. liked to keep wine in lead pots because it became 
sweetened by the lead acetate (called for long lead sugar) generated in the interaction of the 
wine (that must have been rather sour, with so much acetic acid present) with the wall of the 
vessel. Lead was also used in building, in shipbuilding, and in the famous Roman water 
supply system. There are studies stating that the decline of the Roman Empire was promoted 
by their aristocracy’s chronic lead intoxication via wine and aqueduct water (Eaton and 
Robertson, 1994). 
Mercury (for us, another notoriously toxic metal) was also popular in the antique and 
medieval times and was amply used in beauty products and medicines of those ages, but these 
often proved to be rather harmful. The first Chinese emperor, Qin Shi Huang-Di, died in 
multi-organ failure after drinking a liquid mercury preparation promising „eternal life”. 
Cinnabar (HgO, the main ore of this metal) is still in use in traditional Chinese medicine. 
Today’s rapidly growing industry and agriculture is almost forced to use ever newer 
materials, including metal-based ones. The resulting chemical risk, manifested in 
environmental and human health damage, is present even today, in spite of the more and more 
strict regulations which have been evolving from the numerous negative lessons of past 
centuries. Xenobiotics – substances which are “alien” for the metabolism, which can be 
neither utilized nor neutralized by the organism in question – are found in soil, groundwater, 
drinking water, air and, consequently, in plants and animals. In this aspect, a lot of metals are 
xenobiotics because they used to have minimal presence (and, hence, bioavailability) before 
man-made emission into the environment had begun, and because they either are completely 
useless and toxic for the human organism (e.g. mercury, lead or cadmium) or are essential 
micronutrients but toxic when overdosed (manganese, chromium, copper, etc.). Regarding the 
multitude of applications of metals in our days, the broad spectrum of toxic effects of heavy 
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metals (see below) and their consequences; as well as the varieties of their possible entrance 
into the organism, it is of utmost importance to learn more about this problem, among others 
by animal experiments based on more and more adequate models. 
 
1.2. Toxicity of heavy metals and nanoparticles: general aspects 
 
1.2.1. Typical forms and ways of heavy metal exposure. Importance of nanoparticles 
 
Exposure to heavy metals is mostly occupational. Metal-containing dusts and fumes are 
generated along the complete life cycle of metal articles, from ore mining through smelting 
and final product manufacturing to waste management and recycling, and are found in the 
workplace atmosphere, sometimes at hazardous concentrations. Airborne metals cause 
primarily inhalational exposure, the extent of which is influenced by numerous factors 
including the type (nasal/oral), volume and intensity of breathing on the exposed organism’s 
side, and on the other side by the chemical form in which the metal is present in the particles 
(solubility, etc.) and the particle size. According to particle diameter, one can speak of 
sedimenting dust (>10 µm), suspended or fine dust (100 nm-10 µm; often called PM10) and 
ultrafine dust or nanoparticles (NPs, <100 nm). Traditionally, PM10 received especial 
attention because this “thoracic” fraction can reach the alveoli by inspiration and cause toxic 
alveolitis, and because they can cause systemic exposure due to particle-laden alveolar 
phagocytes being transported by lymph, then blood, circulation to other body parts. Larger 
grains are, on the contrary, trapped in the upper airways. 
However, as soon as it became technically possible to investigate the origin and 
environmental presence of NPs and their interaction with living organisms, they turned out to 
have important health effects on their own. All high-temperature industrial processes – 
smelting, casting, welding, etc. of metals (Antonini et al., 2003) or plastics (e.g. Teflon: 
Seidel et al., 1991) – can generate NPs, and various combustion processes are not less 
important NP sources. NPs are emitted as primary (pre-formed) particles or are generated 
from gaseous precursors in an atmospheric chemical process called nucleation. Their 
composition is determined by the composition of the materials worked with or burnt. So, in 
the heavy metal exposure of the general population the metal content of petrol – lead (largely 
phased out, in Hungary since 1999: Kertész et al., 2001) or manganese (still in use as lead 
supplement, to increase octane rating, in a few countries: Davis, 1998) – played a major role 
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because most of the metal left the engine with the exhaust gases in form of microscopic and 
submicroscopic oxide particles. 
Intentionally manufactured nanomaterials (that is, not the nano-sized byproducts from other 
industrial processes) contain at least one component that has at least one dimension in the 1-
100 nm range. Nanomaterials may add to the load of primary NPs in the workplace 
atmosphere. Application of NPs and nanofibres in consumers’ commodities (personal care 
products, household chemicals, electronics, tires, etc.: Oberdörster et al., 2005) means that 
routes of uptake such as ingestion and dermal absorption must be considered in addition to 
inhalation. 
On inhalation, particles are deposited at different section of the airways, determined first of all 
by their size. NPs are either deposited in the nasopharynx or get down to the alveoli (ICRP, 
1994). A fundamental difference against microscopic and larger particles is that NPs are not 
held back by the usual biological barriers like the alveolar and capillary wall, and reach other 
target organs, beside being phagocyted like the PM10 fraction, by different transfer routes and 
mechanisms. One such mechanism is transcytosis across epithelia of the respiratory tract into 
the interstitium (Oberdörster et al., 2005) by means of caveolae (50-100 nm sized 
invaginations of the cell membrane, serving endo- and transcytosis of a number of molecules 
and microstructures: Razani and Lisanti, 2001) formed around NPs. Having crossed the 
alveolar and capillary membrane, NPs are distributed throughout the body by the circulation 
(Oberdörster et al., 2005).  
The NPs’ small size and large specific surface area, together with the high numbers of NPs 
entering the organism in a typical exposure situation, result in great biological activity. In 
vivo and in vitro toxicological studies confirmed that even relatively inert materials become 
more toxic and inflammatogenic in NP form. It was found, e.g., that nanosized TiO2 (ca. 20 
nm diameter) caused more severe inflammation than the same compound in pigment grade 
(ca. 250 nm) grains (Oberdörster, 2000). “Titanium white” as pigment is normally harmless 
enough to be applied in the coating of tablets. The mentioned problem is general, concerning 
both nano-sized environmental pollutants and nanotechnological products. 
NPs can contribute to adverse health effects in the respiratory tract as well as in 
extrapulmonary organs (Oberdörster et al., 2005). A healthy blood-brain barrier is supposed to 
prevent foreign particles from entering the brain; NPs of various compositions were, however, 
detected in the brain of rats after application through the airways (Kreyling et al., 2006). Such 
extrapulmonary effects of NPs depend on several factors including particle solubility, particle 
or aggregate size, the site of deposition, and the integrity of the alveolar epithelial lining 
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(Elder et al., 2006). Metal ions dissolved from the surface of metal-containing NPs in the 
acidic microenvironment of phagosomes – after the NPs had been phagocyted by alveolar 
macrophages (Lundborg et al., 1985) – also must be considered among the mechanisms of 
action. The applicant’s results with Cd exposure supported the interpretation that the blood-
brain barrier may be weakened by the toxic metal ions and so will be more permeable for NPs 
(Horváth et al., 2011)  
Apart from inhalation, the second most important route of exposure to heavy metals is 
probably ingestion. Airborne particles can be ingested if expectorated airways secretions are 
swallowed instead of being spat. Dust can contaminate food or drink, e.g. under unhygienic 
eating conditions at the workplace or if dust particles are captured on the surface of raw-eaten 
vegetables and fruits that have not been washed adequately. The settled particles’ metal 
content can also be directly incorporated into the edible parts of the plants, or soil pollution by 
the particles can result in toxic metals being absorbed from the soil to the plants. 
Both mechanisms were evidenced by the samples taken near to the defunct metal reprocessing 
plant “Metallokémia” in Budapest. This plant was reprocessing copper, zinc, lead and other 
metals from 1908 on. Lead smelting was stopped in 1977 but other metals were processed 
until the end of activities in 1990 and the byproducts (slag containing heavy metals) were 
stored on the plant’s premises further on (Pápay and Horváth, 1992). Windblown dust was 
settling on the soil and on plants grown in the local residents’ gardens. Downwind, near the 
factory, more than 1000 mg/kg Pb was in the upper soil, 1000 m farther away it was 100 
mg/kg, at 2000 m, 50 mg/kg. Cd level near the plant was 3-6 mg/kg. Pb content of the 
groundwater was three times, and Cd content eight times, the allowable limit (Szabó, 1991). 
Leafy vegetables contained Pb over the limit in 40-50%, root vegetables in 8-50%, and 
various fruits in 24-40%. Pb in the soil and in the produces was loosely correlated, but for Cd 
levels the correlation was robust. The local children’s blood Pb level was higher if they lived 
nearer to the factory; and among those living within the 500 m radius, eating or not eating 
home-grown fruits or vegetables had a considerable influence on blood Pb (Groszmann et al., 
1992). 
Incorporation and accumulation of toxic metals from the soil is characteristic for numerous 
plants, including ones used for staple food production, the case cadmium content in rice being 
repeatedly cited (Shigematsu, 1984). 
From the intestines, most heavy metals are absorbed to around 10%. Common metal transport 
mechanisms, responsible for the uptake of essential metals, are involved, which explains why 
individuals with calcium- or iron-deficiency absorb more of the toxic metals. Children, 
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requiring much calcium for bone growth, can absorb 50% of the ingested lead while adults 
absorb not more than 15% (Järup, 2003). Toxic metals are transported as “dead-heads” not 
only from the intestine to the blood but also from the blood through the blood-brain barrier to 
the CNS. Trivalent metal ions, like Mn3+ or Al3+, use transferrin to pass the blood-brain 
barrier; aluminium being the culprit for “dialysis dementia”, a kind of brain damage seen in 
dialysed patients. 
The dermal absorption route is less well described, but presence of soil particles in inguinal 
lymph nodes of persons who usually walk barefoot on the soil indicate that this is possible 
(Oberdörster et al., 2005). Also some viruses, being NPs by their size, can cause transdermal 
infection. 
 
1.2.2. General mechanisms of heavy metal toxicity 
 
Heavy metals exert a profound action on living matter, affecting the growth, metabolism, 
morphology of cells. 
Denaturation of proteins is one of the general damaging effects of heavy metals. The metal 
ions interact with ionized moieties of amino acids in the polypeptide chain and disrupt the 
non-covalent polar and ionic interactions which stabilize the secondary (or higher order) 
structure of the protein. The covalent link provided by disulfide bridges is also attacked by 
numerous heavy metal ions. Lead and cadmium have an especial affinity to sulfur, even their 
most abundant ores are sulfides. This chemically-based destructive effect of heavy metals on 
the most essential constituent of all living organisms – that is, a type of toxicity – can also be 
exploited as a means of antimicrobial protection (e.g., in Credé’s solution and in 
organomercurial antiseptics), but for the purposes of this thesis the metals in question are 
regarded as human (neuro)toxicants. 
Denaturing an enzyme protein means elimination its biocatalytic activity. Glutathion-S-
transferase was, e.g., reported to be inactivated by lead (Daggett et al., 1997) or lead and 
cadmium (Planas-Bohne and Montserrat, 1992). This also exemplifies that disturbed redox 
balance and oxidative stress is another frequent consequence of heavy metal exposure. Some 
of the toxic heavy metals (iron, chromium, manganese) are capable of redox cycling while 
others (e.g. cadmium) affect cellular antioxidant defence (Valko et al., 2005). Apart from that, 
all NPs, with or without toxic metal content, tend to be absorbed to organic macromolecules 
(possibly resulting in altered functionality) and to induce oxidative stress (Li et al., 2003). 
NPs generate reactive oxygen species more intensely than larger particles, leading to 
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increased synthesis of pro-inflammatory mediators via intracellular signalling pathways (Long 
et al., 2007; Stone et al., 2007). 
It has long been known that many cellular functions (among others, muscle contraction, 
exocrine and endocrine secretion) are regulated by local changes in Ca2+ concentration. 
Increased intracellular Ca concentration is essential for intracellular enzyme activation and for 
neurotransmission in chemical synapses. Ca2+ ion is also a charge carrier, carrying inward 
current via selective voltage- and ligand-gated Ca channels. The latter are parts of the 
postsynaptic (e.g. glutamate or nicotine-type acetylcholine) receptors so that neither side of a 
chemical synapse can function properly in case another metal interferes with Ca (Malenka and 
Nicoll, 1999). Voltage-gated Ca channels are blocked by a variety of divalent and trivalent 
metal cations including manganese (Pumain et., 1987); as well as lead, mercury and zinc 
(Büsselberg, 1995). Disturbed neurotransmission also belongs to the toxic spectrum of certain 
neurotoxic heavy metals (Braga et al., 1999; Takeda et al., 2003). 
In the trafficking of metals between parts of the cells, and between different cells or tissues, 
metallothioneins play an important role. These are relatively small (500-14000 Da) proteins 
unusually rich in cysteine units. By means of the sulfhydryl groups, metallothioneins bind a 
range of metal ions. Physiological metals (like zinc and copper) are bound, stored and 
transported to the appropriate sites, while toxic ones (mercury, cadmium, etc.) are neutralized 
by the binding. The presence of –SH groups provides metallothioneins with antioxidant 
properties. Both metal exposure and oxidative stress (which can also be linked, see above) can 
induce the synthesis of metallothioneins. 
 
1.3. Properties and toxicity of manganese 
 
In pure state, manganese (Mn) is a silvery-grey, hard and brittle metal. It finds practical 
application in a variety of alloys and compounds. Mn can have a series of oxidation states 
between 2 and 7. For all living organisms, Mn is an essential trace element, but toxic when 
overdosed. The human body contains about 10 mg Mn, stored mainly in the liver and kidneys. 
The daily demand is 2-3 mg (ATSDR, 2008b). Mn is a component in many enzymes, e.g. in 
one of the superoxide dismutases (Mn-SOD; Law et al., 1998) playing important role in 
counteracting oxidative stress. Glutamine synthetase, alkaline phosphatase, arginase, and 
pyruvate carboxylase also contain Mn (Quintanar, 2007). Glutamine synthetase (a glia-
specific Mn metalloprotein) catalyzes in the CNS the conversion of glutamic acid to 
glutamine, thereby inactivating the transmitter. This enzyme requires Mn, but is inhibited by 
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its excess which is of importance in the neurotoxic mechanisms of Mn (Normandin and 
Hazell, 2001). 
Mn can be found, to various amounts, in all soils; originating from weathering of rocks and 
volcanic activity. The latter emits also atmospheric Mn, but today the main Mn load comes 
from man-made pollution (mining and metal industry, the above-mentioned fuel additive, 
etc.). Mn is found in steel and other alloys, and also in the coating of welding rods (for 
protection of the glowing hot welded metal parts from oxidation). MnO2 is used in the 
production of dry cells. Mn is also used in paints and for glass and ceramics. 
Methylcyclopentadienyl manganese tricarbonyl (MMT) was an anti-knock petrol additive the 
use of which is still allowed in certain countries. Semiconductor nanocrystals (Yang et al., 
2005) and ZnS:Mn2+ nanoflowers (three-dimensional synthetic nanostructures; Chen et al., 
2005) represent the use of Mn in nanotechnology. Mn is used in certain agricultural 
fungicides (Maneb, Mancozeb; Ferraz et al., 1988). A new application with direct human 
exposure is in magnetic resonance imaging for diagnostic use, in form of the contrast agent 
trisodium mangafodipir (Mn-DPDP, Teslascan). 
Chronic inhalation of manganese compounds is the typical form of occupational Mn 
exposure. The resulting “manganese madness” among ore miners was first reported in the 19th 
century (Couper, 1837). The Mn-related chronic neurological disorder is today called 
manganism, and it usually progresses in three stages (Saric et al., 1977; Calne et al., 1994). 
The symptoms are nonspecific like apathy, anorexia, asthenia, headache, hypersomnia, 
spasms, arthralgia, weakness of the legs, and irritability. In the second stage, psychomotor and 
psychic disturbances dominate, such as dysarthria, excess salivation, and difficulty in 
walking. The third stage represents a Parkinson-like syndrome with its associated symptoms. 
But, in spite of the similar symptoms, the site of damage in manganism and in Parkinson’s 
disease is different. The site of action for Mn are the striatal, and not the mesencephalic, 
dopaminergic neurons (Erikson and Aschner, 2003). 
Inhalation is, however, not the only way of Mn exposure leading to CNS damage. Parkinson-
like disorder was also observed in patients undergoing maintenance hemodialysis (Ohtake et 
al., 2005) or in inadvertent overdosing due to long-term ingestion of a health supplement 
containing high levels of Mn. This indicated that other physicochemical forms of Mn and 
other routes of exposure are also relevant to the health of the CNS (and deserve being 
included in neurotoxicological studies). For geological reasons (e.g. in Greece: Kondakis et 
al., 1989) or due to man-made pollution (such as improper disposal of used dry cells in Japan: 
Kawamura et al., 1941) abnormally high Mn levels in the drinking water were observed, 
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causing CNS symptoms in the affected population. In regions of the USA with high-Mn 
drinking water, loss of visual and verbal memory, typical for Mn-induced brain damage, was 
described (Woolf et al., 2002). Foodborne overexposure by Mn in babies fed on cow milk- or 
soybean-based formulas was reported (Marlowe and Bliss, 1993) as was 
hypermanganesaemia following long term parenteral nutrition (Crook, 2001). 
The neurotoxic spectrum of Mn is variable and goes beyond the classical manganism. 
Epileptic activity was observed in children following inhalational (Hernandez et al., 2003) or 
parenteral (Komaki et al., 1999) exposure; and myoclonus in welders (Ono et al., 2002). In 
young shipyard workers, EEG and visual evoked potential alterations were observed and 
blood Mn levels up to 14 µg/L were measured (Halatek et al., 2005), while in reference 
groups blood Mn is 5–7 µg/L (Bader et al., 1999). EEG and evoked potential disturbances 
following occupational Mn exposure were also reported by Sinczuk-Walczak et al. (2001) and 
Sjögren et al. (1996). 
 
1.4. Properties and toxicity of lead 
 
Lead (Pb) is a soft, malleable metal with low melting point. It is one of the oldest metals 
mined and used. Egyptians and Romans widely used this metal in everyday life (see above). 
In antique Rome, 4 kg lead was used per year and person, compared to 6 kg in the United 
States in 1965. From Gutenberg’s times to the advent of photo typesetting, printing 
technology was based on types cast from Pb-based alloys. In spite of the known toxic effects, 
Pb remains to be used in several large-scale applications, an example being lead-acid batteries 
found in motor vehicles, in emergency power supplies, etc. Also, leaded car fuel disappeared 
from the market only in the last 15 years, so that in the mid-90’s, approximately 90% of all Pb 
emission into the atmosphere was due to leaded petrol (Lovei, 1996). Lead-based pigments, 
like lead white (PbCO3) and minium (Pb3O4) are no more used but demolition or renovation 
of old buildings or iron structures (bridges, ships) painted originally with such paints can 
expose the workers involved. On one criminal occasion, minium was used in Hungary to 
improve the color of ground red paprika (Kákosy et al., 1995, 1996). Today, half of the newly 
produced lead articles are made of recycled lead, which is good for the environment but the 
occupational hazard is the same. Hot molten lead emits metal fumes consisting of microscopic 
and submicroscopic aerosol particles. In absence of proper safety measures, working with 
lead results in serious intoxication, as shown, among others, by the case of the illegal battery 
recyclers in Heves (Epinfo, 1995). 
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Pb has no biological functions, it is purely toxic. It is also one of the most common 
environmental xenobiotics (present in soil, groundwater, air, and foodstuffs) for which the 
large-scale and careless use during previous centuries is to blame. Occupational health 
damage due to Pb used to be so grave that a separate “Lead Examination Station” 
(Ólomvizsgáló Állomás, an early predecessor of the present National Institute of 
Occupational Health) was set up in Hungary in 1934 (Galgóczy, 1999) 
The general population is exposed mainly by contaminated drinking water or food: roots, 
leafy vegetables, meats, dairy products or fishes (ATSDR, 1999). High Pb level in home-
grown vegetables was a major source of risk also in the above-mentioned case of the 
Metallokémia plant. Tobacco smoke is another notable source of Pb exposure. By the oral 
route, 5-50% of Pb is absorbed; but by inhalation, almost the complete amount. Before the 
ban of leaded petrol, the population had, mainly in urban areas and along main roads, 
significant airborne Pb exposure (Rudnai et al., 1998). Pb is accumulated in the central 
nervous system, first of all in the cortex and hippocampus (Gerhardsson et al., 1995), and 
produces encephalopathy at blood Pb levels of 1000-1200 µg/L in adults and 800-1000 µg/L 
in children (Chisolm, 1965). Exposure to low levels of Pb has been associated with behavioral 
abnormalities, learning impairment, decreased hearing, and impaired cognitive functions in 
humans and in experimental animals (Shannon and Graef, 1992; Ruff et al., 1996). Some 
estimates suggest that, in exposed children, every 100 µg/L increase in blood Pb level is 
associated with a 1-5 point decrease in the IQ (Goyer, 1996). IQ differences in Hungarian 
schoolchildren, attributable to airborne Pb, were published by Füzesi (1997). Pb can also pass 
the placenta and cause serious damage to the nervous system before birth. In workers with 
chronic Pb exposure, less severe neurologic effects were documented with headache, lethargy, 
dizziness, diminished reaction time, worsened cognitive and visuomotor performance, and 
slowed nerve conduction (Lille et al., 1988; Araki et al., 2000). 
 
1.5. Properties and toxicity of cadmium 
 
Cadmium (Cd) is a soft, malleable bluish-white metal with low melting point. It has no 
biological function in higher-order organisms and is toxic even in small amounts. It is 
chemically related to zinc which explains several of its toxic effects. 
Cd has been used for industrial purposes since the 19th century. The most significant 
application of Cd used to be in corrosion resistant electroplating layers on steel. Metallic Cd 
and its compounds were also used as pigments, UV-resistance stabilizers in plastics, coatings, 
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special alloys, Cd-based semiconductors, and on large scale in rechargeable Ni-Cd batteries. 
Such applications resulted in significant workplace exposure, mainly by inhalation. However, 
due to the toxic hazard involved, the use of Cd has been largely reduced in the last 20 years – 
but novel technologies and materials using Cd appeared in the meantime, like quantum dots 
(Rzigalinski and Strobl, 2009). 
The presence of Cd in the elements of environment (air, soil, groundwater, etc.) is to a large 
part due to human activity, and the general population is exposed mainly by contaminated 
drinking water or food. Cd is emitted into the environment with solid and liquid industrial 
(and to a lesser extent, residential) waste. The fertilizer superphosphate can also contain 
significant amounts of Cd (tens of mg/kg) originating from the mineral raw material, leading 
to build-up of Cd in the treated fields (Syers et al., 1986). 
Cd is one of the most toxic environmental and industrial pollutants because it can damage, all 
important organs (ATSDR, 2008a) and also the CNS (Méndez-Armenta, 2007). It is a Group 
1 human carcinogen (IARC, 1993). 
Inhalation of Cd containing aerosol is typically an industrial hazard. Depending on the size of 
the particles, airborne Cd is absorbed from the respiratory tract to 2-50% (Chaney et al., 
2004). In a published acute case of intoxication due to Cd inhalation, the victim had first 
respiratory signs which transformed over 3-6 months to a Parkinson-like state (stiffness of the 
limbs, bradykinesia, muscle stiffness) that did not improve on antiparkinsonian medication 
(Okuda et al., 1997). Amyotrophic lateral sclerosis, optic nerve damage, striatal damage and 
peripheral polyneuropathy were also observed as long term neurotoxic consequences of Cd 
(Bar-Sela et al., 2001; Fern et al., 1996; O’Callaghan and Miller, 1986; Viaene et al., 1999). 
At population level, Cd exposure is mostly foodborne, an important exception being tobacco 
use. Tobacco plants accumulate the metal in the leaves so that one cigarette may contain 1–2 
µg Cd. Of that, ca. 10% is inhaled, and approximately 50% of that is absorbed in the lungs 
(Elinder et al., 1983). By smoking 20 cigarettes day, a person’s internal daily Cd dose is ca. 1 
µg. 
Several other cultivated plants, most notably cereals, also tend to take up Cd from the soil 
(Järup, 1998). Cd accumulates easily via the food chain: its level can reach 10 µg/kg in crops 
(grain, fruits, vegetables) but goes up to 100-1000 µg/kg in offal (kidney and liver). Shellfish 
can contain 200-2000 µg/kg Cd (Galal-Gorchev, 1991) but are themselves not poisoned, 
surprisingly. 
Gastrointestinal absorption of Cd in humans is 5-20% (Chaney et al., 2004). Absorbed Cd is 
transported via the blood to the main target organs such as lung, kidney, liver, bones, brain, 
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testis, even to the placenta (Casalino et al., 2002; Méndez-Armenta et al., 2003; Morselt et al., 
1991; Wier et al., 1990). 
In children, a straight relationship between hair Cd and altered visual or auditory evoked 
potential parameters was found (Thatcher et al., 1982), and school behavioral problems were 
reported (Marlowe et al., 1985). 
As to mechanism of neurotoxicity, Cd2+ can block the influx of Ca2+ in the presynaptic 
terminal, which may result in altered transmitter release (Antonio et al., 1998). Excitatory 
neurotransmitters (glutamate and aspartate) were found decreased, while the inhibitory 
neurotransmitters (glycine and GABA) were increased in the amygdala of Cd-exposed 
animals, suggesting that Cd affects the balance of excitation/inhibition in synaptic 
transmission (Minami et al., 2001). Contents of dopamine, serotonin and norepinephrine in 
adult male rats were found decreased in all brain regions after a 24 h exposure to Cd 
(Lafuente et al., 2003). Cd is also potent inhibitor of the brain (Na+/K+)-ATPase (Antonio et 
al., 2002), and inhibits choline transport in synaptosomes (Chandra et al., 1994). 
Beside the nervous system, Cd damages its typical sites of deposition, liver and kidneys, and 
the bones. The latter is due to a Zn/Cd competition at the active centre of bone alcalic 
phosphatase (E + Zn2+, Cd2+ → CdE + Zn2+) which results in bone material loss and 
pathological fractures. Vertebral fracture and the subsequent pain (“itai-itai” is a painful cry in 
Japanese) were described from Japan where a rice field was flooded with metal-laden 
industrial wastewater (Shigematsu, 1984). 
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1.6. Aims 
 
As described in the previous sections, human exposure to certain environmental heavy metals, 
where the workplace environment is a leading source of exposure, has been a major issue of 
hygiene at population level. Any effect of these metals on the nervous system deserves 
especial attention, because of the importance of the affected functions in the quality of life 
and productivity at the level of individuals, and because mental power (depending on healthy 
brains) is a most precious human resource. 
In previous experiments at the Department it was found that recording and analysis of central 
and peripheral electrophysiological signals, and of certain behavioral phenomena, is 
sufficiently sensitive to detect the effects of lead, cadmium and manganese on the nervous 
system of rats, applied subacutely in dissolved form orally (Nagymajtényi et al., 1997; Papp 
et al., 2003; Vezér et al., 2005) or in the form of nanoparticles by intratracheal instillation 
(Oszlánczi et al., 2010a). In order to obtain a more adequate model, these two forms of metal 
application were combined in the present work to imitate exposure coming both from 
environmental (food/waterborne) and occupational (inhalational) sources. 
 
The aims of the work were specified in the following questions: 
• Are the treatment schemes and doses used previously for application of manganese, lead 
and cadmium in dissolved form orally, and in nanoparticulate form intratracheally, 
usable also in combination exposure? 
• What quantitative and qualitative differences can be observed in the general 
toxicological, electrophysiological and behavioral changes obtained by applying the 
mentioned metals only in dissolved oral form, only in nanoparticulate intratracheal 
form, and in combining these forms of application? 
• Is the dose-response relationship in oral-only, intratracheal-only, and combined 
application different? 
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2. MATERIALS AND METHODS 
 
2.1. Experimental animals and chemicals 
 
Young adult male Wistar rats (280–350 g body weight at start) obtained from the Breeding 
Centre of the University, were used for the experiments. The animals were housed under 
standard conditions (22–24 °C, 12 h light/dark cycle with light on at 6:00 a.m., up to four rats 
in one cage) with free access to conventional pellet food and drinking water. 
The three metals, Mn, Cd and Pb, were administered to the rats in two physicochemical forms 
and two ways. Aqueous solution was given orally by gavage (per os, po.), while the 
suspension of NP form was instilled in the trachea (intratracheally, it.). The chemical identity 
and dose of the substances applied to the rats is given in Table 1. 
 
Table 1  The substances used for treatment 
Metal Compound Doses (mg/kg b.w.) 
Manganese   
  dissolved form MnCl2⋅4H2O 15, 60 
  nanoparticulate form MnO2 2.63 
Cadmium   
  dissolved form CdCl2⋅2.5H2O 3.5 
  nanoparticulate form CdO2 0.04 
Lead   
  dissolved form Pb(CH3COO)2⋅3H2O 80, 320 
  nanoparticulate form PbO 2 
 
For oral application, the compounds given in Table 1 were dissolved in distilled water to 1 
ml/kg b.w. administration volume. Metal salts with high water solubility and non-toxic anion 
were chosen for po. administration to imitate the presence of metals in food and drink. The 
NPs used for it. application were oxides, because methods to produce them were found in the 
literature and because metal oxide NPs are found in real-world emissions e.g. in welding 
fumes. The final form, exerting toxic effects, is most probably a metal ion, absorbed from the 
intestine or dissolved from the surface of NPs in the phagosomes of alveolar macrophages. In 
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case of NP application, their own surface effects, resulting e.g. in oxidative stress, are also 
present. 
The NPs were synthesized at the Department of Applied Chemistry, University of Szeged 
Faculty of Science and Informatics. MnO2 NPs were made by a technique combining 
sonication and hydrothermal treatment. An appropriate amount of aqueous KMnO4 solution 
was mixed with ethylene glycol and sonicated with a Hielscher UIP1000 ultrasound device. 
The resulting dark suspension was loaded to a Teflon-lined stainless steel autoclave. The 
autoclave was heated at 200°C for 16 h in an oven and then allowed to cool to room 
temperature naturally. The brownish precipitate formed was filtered and washed with 80°C 
preheated distilled water to remove any unreacted starting material and the soluble byproducts 
formed during the reaction. The precipitate was dried at 100°C for 1 hour. 
CdO2 NPs were synthesized by a dry process. Stochiometric amount of CdCl2 and Na2CO3 
were put, using NaCl as matrix, in the drum of a planetary ball mill (Fritsch Pulverisette 6) 
and rotated with 20 stainless steel mill balls at 400 rpm for 4 hours (reaction 1: CdCl2 + 
Na2CO3 → CdCO3 + 2 NaCl). The mixture milled this way was then calcined at 480 °C for 4 
hours in air (reaction 2: CdCO3 + ½ O2 → CdO2 + CO2). After calcination, the synthesis 
mixture was filtered (0.45 µm PTFE membrane filter) and washed with 80°C preheated water 
to remove any unreacted starting material and the soluble NaCl matrix. The precipitate was 
dried at 100 °C for 1 hour. 
PbO NPs were produced in a similar way, milling a mixture of Pb(CH3COO)2 and NaOH 
(reaction 1: Pb(CH3COO)2 + 2 NaOH → 2 Na(CH3COO) + Pb(OH)2 ). After calcination 
(reaction 2: (Pb(OH)2 → PbO + H2O), the mixture was washed and filtered as above. 
 The chemical purity of the nanoparticles was checked by X-ray diffraction, and their particle 
size, by X-ray diffraction and transmission electron microscopy. The size histograms and 
images of the NPs are shown in Fig. 1. 
For intratracheral administration, the NPs were suspended in 1% hydroxyethyl cellulose 
(HEC) dissolved in PBS (pH 7.4). This vehicle was physiologically neutral and slowed the 
aggregation of the NPs. The suspension was intensively sonicated as it was made, and was 
sonicated again before administration. 
Diethyl ether (used for brief anesthesia) and HEC was obtained from the Central Pharmacy of 
the University of Szeged. Materials for synthesis of the NPs and for po. metal treatment, and 
urethane for terminal anesthesia (see below), were purchased from Reanal, Budapest. 
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Figure  1  Transmission electromicrographs (left) and size histograms (right) of the NPs used in the 
experiments. Mean diameters of the NPs are also indicated. 
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2.2. Modes and time schemes of treatment 
 
Gavage (for po. application) was performed using an appropriately bent and fire-polished thin 
glass tube attached to a 1 ml syringe. Gavage could be performed on awake rats. 
For it. instillation, the animals had a brief diethyl ether anesthesia. The rat was put in a glass 
jar with air-tight lid, saturated with ether vapor. The completely anesthetized rat was 
suspended, on a board tilted to 60° from horizontal, by hanging its upper incisors in a wire 
loop. Keeping this way the rat in place and its mouth open, the trachea was illuminated 
transdermally by means of a fibre optic light guide brought into direct contact with the 
animal’s neck. The tongue was pulled forward with a pair of non-traumatic forceps, and a 
custom-made laryngoscope was used to gain access to the glottis. The NP suspension (or the 
vehicle, 1% HEC in the controls) was instilled into the trachea by means of a 1 ml syringe and 
1.2 mm diameter plastic tubing, inserted between the vocal chords. Before taking up the 
materials, an equal quantity of air was drawn into the syringe, and was pushed out after the 
suspension to assure that the whole amount was emptied from the syringe and tube and 
delivered into the trachea. Treatment was performed under an exhaust hood to remove ether 
vapors. 
The time scheme of treatment was, based on previous experience, determined so that 
detectable effects could be obtained in a reasonable time span. The basic idea, outlined in 
Aims, was to treat the rat first orally to imitate food/waterborne background exposure, then to 
apply intratracheal treatment, as if it were by workplace metal fumes. This was to be realized 
in a 3 and 6 weeks treatment scheme presented in Table 1. The treatment started with 3 or 6 
weeks po. administration of the doses given in Table 1, to 2 x 10 rats. Then half of the group 
was finished (underwent behavioral and electrophysiological investigation, and was dissected) 
while the other half was further treated by it. administration for an equal length of time (3 or 6 
weeks). This scheme worked well with Mn and Pb but produced too high general toxicity and 
excessive loss of animals in case of po.+it. Cd treatment. So, a different scheme with shorter 
it. application period was used instead, with only one po. dose, and it. application was done 
before, and also after, po. treatment (in two different groups, see Table 2C). All the same, the 
controls and the Cd3 group of thee first (abandoned) experiments with Cd exposure were 
usable and are included in the evaluation. 
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Table 2  Treatment schemes 
A. Manganese treatment 
 
Group code  Substance and dose (mg/kg b.w.) Treatment time 
MnC3 untreated 3 weeks 
MnVC3 distilled water, per os 3 weeks 
MnL3 MnCl2 15 mg/kg b.w. po. 3 weeks 
MnH3 MnCl2 60 mg/kg b.w. po. 3 weeks 
MnC33 untreated* 6 weeks 
MnVC33 
distilled water, po. 
+ 
HEC it. 
3 weeks 
 
3 weeks 
MnL33 
MnCL2 15 mg/kg b.w. po. 
+ 
MnO2 NPs 2.63 mg/kg b.w. it. 
3 weeks 
 
3 weeks 
MnH33 
MnCL2, 60 mg/kg b.w. po. 
+ 
MnO2 NPs 2.63 mg/kg b.w. it. 
3 weeks 
 
3 weeks 
MnC6 untreated* 6 weeks 
MNVC6 distilled water, po. 6 weeks 
MnL6 MnCl2 15 mg/kg b.w. po. 6 weeks 
MnH6 MnCl2  60 mg/kg b.w. po. 6 weeks 
MnC66 untreated 12 weeks 
MnVC66 
distilled water, po. 
+ 
HEC it. 
6 weeks 
 
6 weeks 
MnL66 
MnCl2, 15 mg/b.w. kg po. 
+ 
MnO2 NPs 2.63 mg/kg b.w. it. 
6 weeks 
 
6 weeks 
MnH66 
MnCl2, 60 mg/b.w. kg po. 
+ 
MnO2 NPs 2.63 mg/kg b.w. it. 
6 weeks 
 
6 weeks 
* C33 and C6 were two different groups. 
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B. Lead treatment 
 
Group code  Substance and dose (mg / kg b.w.) Treatment time 
PbC3 untreated 3 weeks 
PbVC3 distilled water, po. 3 weeks 
PbL3 Pb(CH3COO)2, 80 mg/kg b.w. po. 3 weeks 
PbH3 Pb(CH3COO)2, 320 mg/kg b.w. po. 3 weeks 
PbC33 untreated* 6 weeks 
PbVC33 distilled water, po. 
+ 
HEC it. 
3 weeks 
 
3 weeks 
PbL33 Pb(CH3COO)2, 80 mg/kg b.w. po. 
+ 
PbO NPs 2 mg/kg b.w. it. 
3 weeks 
 
3 weeks 
PbH33 Pb(CH3COO)2, 320 mg/kg b.w. po. 
+ 
PbO NPs 2 mg/kg b.w. it. 
3 weeks 
 
3 weeks 
PbC6 untreated* 6 weeks 
PBVC6 distilled water, po. 6 weeks 
PbL6 Pb(CH3COO)2, 80 mg/kg b.w. po. 6 weeks 
PbH6 Pb(CH3COO)2, 320 mg/kg b.w. po. 6 weeks 
PbC66 untreated 12 weeks 
PbVC66 distilled water, per os 
+ 
HEC intratracheally 
6 weeks 
 
6 weeks 
PbL66 Pb(CH3COO)2, 80 mg/kg b.w. po. 
+ 
PbO NPs 2 mg/kg b.w. it. 
6 weeks 
 
6 weeks 
PbH66 Pb(CH3COO)2, 320 mg/kg b.w. po. 
+ 
PbO NPs, 2 mg/kg b.w. it. 
6 weeks 
 
6 weeks 
* C33 and C6 were two different groups of rats. 
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C. Cadmium treatment 
 
Group code  Substance and dose (mg / kg b.w.) Treatment time 
CdV3 distilled water, po. 3 weeks 
Cd3 CdCl2 solution, 3.5 mg/kg  b.w. po. 3 weeks 
CdV13 HEC, it. 
+ 
distilled water, po. 
1 week 
 
3 weeks 
Cd13 CdO2 NPs, 0.04 mg/kg b.w. it. 
+ 
CdCl2 solution, 3.5 mg/kg  b.w. po. 
1 week 
 
3 weeks 
CdV31 distilled water, po. 
+ 
HEC, it. 
3 week 
 
1 weeks 
Cd31 CdCl2 solution, 3.5 mg/kg  b.w. po. 
+ 
CdO2 NPs, 0.04 mg/kg b.w. it. 
3 week 
 
1 weeks 
 
The doses given in Table 2 have been used in previous works of the Department (Pb oral: 
Pecze et al., 2005; Mn oral: Vezér et al., 2005; Cd oral: Papp et al., 2003; NP doses: 
Oszlánczi et al., 2010a), and were found to produce clear neuro-functional effects. 
The animals were randomized between groups to avoid significant differences in the starting 
body weight. Body weight was measured before every administration to determine the exact 
daily doses and to follow weight gain. The total dose applied to one rats during the entire 
treatment period was also calculated using the daily weight data. During the treatment period, 
there was one administration every workday (that is, 5 times a week). While handling the 
animals, any sign of general toxicity in their appearance and behavior were observed and 
noted. 
 
2.3. Behavioral investigation by the open field method 
 
At the end of the treatment period (that is, after 3, 6 or 12 weeks metal exposure), open field 
test was done to assess the rats’ spontaneous locomotor activity. The test was performed one 
or two days after the last metal administration, po. or it. An open field box (OF) of 48x48x40 
cm size was used, equipped with two arrays of infrared movement detectors at floor level and 
in 12 cm height (Conducta 1.0 System, Experimetria Ltd, Budapest, Hungary). The test was 
performed between 8 and 11 hours in the morning. Just before the test, the animals were 
allowed to get acclimatized in the dimly lit test room for 30 minutes. One by one, the animals 
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were placed into the centre of the box, for one 10-min session. The instrument recorded the 
animal’s horizontal and vertical motor activity based on the interruptions of the infrared 
beams. From these data, counts, time and run length of the activity forms (ambulation, local 
activity, immobility, rearing) were automatically calculated. More than 40 mm shift in the 
location of interrupted beams at the floor level during a time unit of 1 s was interpreted as 
ambulation (i.e. walking, horizontal activity), less shift, as local activity (motions without 
changing the place), and no shift at all, as immobility. Rearing was recorded if beams at floor 
level and at the higher level were interrupted simultaneously. It was known form previous 
experience (e.g., Vezér et al., 2005) that the OF test was suitable for investigating the 
impairment of higher nervous functions caused by heavy metals. 
 
2.4. Electrophysiological investigation 
 
The electrophysiological recording was done on the same day after the OF test or on the 
following day. The animals were anaesthetized by intraperitoneal injection of 1000 mg/kg 
b.w. urethane (Mook, 2006). The head of the rats was fixed in a head holder, the skin was 
opened by a mid-sagittal cut and the muscles and connective tissues (galea aponeurotica) 
attached to the skull were removed. Finally the left temporal bone was cut along its inner 
circumference by a dental drill bit attached to a mini drill, and the left hemisphere was thus 
exposed. Lidocaine spray (10%) was applied to the wounds and the exposed cortex was 
protected with a thin layer of petroleum jelly. The animals were then wrapped in a warm cloth 
to maintain body temperature and were put aside for at least 30 min for recovery. For 
recording, the rat was placed into the stereotaxic frame of the electrophysiological setup. To 
stabilize body temperature, a thermostated (+36.5°C) base plate was used to support the rat’s 
underside during the recording procedure. 
To record spontaneous and evoked cortical activity, ball-tipped silver recording electrodes 
were positioned on the dura over the primary somatosensory (SS) area (projection of the 
whisker pad, barrel field), and over the primary visual (VIS) and auditory (AUD) area. These 
regions were determined on the basis of a somatotopic map (Zilles, 1984). A stainless steel 
clamp was attached to the cut skin edge as indifferent electrode. SS stimulation was done by a 
pair of needles inserted into the whiskery part of the nasal skin, delivering square electric 
pulses (for stimulation parameters, see below). VIS stimulation was performed by flashes 
delivered by a flash generator via an optical fibre conductor directed into the contralateral eye 
of the rat. For acoustic stimulation, sound clicks were applied into the ear of the rat.  
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The recorded biological signals were amplified (104x), fed into the digitizer interface of the 
recording setup, and stored on PC. The complete recording and evaluation was executed by 
the software Neurosys 1.11 (Experimetria Ltd, Budapest, Hungary). 
The session started with six minutes recording of spontaneous activity (electrocorticogram, 
ECoG) first, from the three sensory cortical areas simultaneously. From the EcoG records, the 
relative spectral power of the frequency bands: delta, 0.5-4 Hz; theta, 4-7 Hz; alpha, 8-13 Hz; 
beta1, 13-20 Hz; beta2, 20-30 Hz; gamma, 30-50 Hz (Kandel and Schwartz, 1985) was 
determined by the software automatically. 
Then EPs from the same cortical areas were recorded via the same surface electrodes. Sensory 
stimuli were delivered by a digital time base and stimulator unit (Experimetria Ltd, Budapest, 
Hungary). All stimuli were set and applied as of just supramaximal strength (meaning that, 
e.g., the stimulus voltage was increased until the evoked response reached maximal amplitude 
and ca. 5% was added) and well above background. Electrical stimulation of the whiskers and 
the base of tail was done by delivering rectangular electric stimuli (3-4 V, 0.05 ms). The 
intensity of the visual stimulation was ca. 60 lux, and that of the auditory stimuli, 40 dB. 
Trains of 50 stimuli were applied and the evoked potentials (EPs) recorded. The standard 
frequency of the stimulation was 1 Hz. Previous studies in our laboratory (Papp et al., 2001, 
2004) demonstrated that varying the frequency of stimulation can sensitively detect the 
dynamic interaction of successive excitation processes in the sensory system which in turn 
reflects the actual state of the CNS. Accordingly, the frequency dependence in the parameters 
of the cortical evoked activity was determined by delivering stimuli to the somatosensory 
system (i.e. to the whisker pad) beyond the standard 1 Hz, also with 2 and 10 Hz frequency.  
Finally, compound action potentials of the tail nerve were recorded. These were evoked by 
means of a pair of stimulating needle electrodes inserted at the base of tail (delivering similar 
electric stimuli as used to stimulate the whiskers), and were recorded distally by another pair 
of needles at a distance of 50 mm.  
Evoked activity (cortical responses and tail nerve action potential) were automatically 
averaged off-line, and their parameters were measured manually by means of screen cursors 
of the software. Exemplified on the SS EP, onset latency was measured between the stimulus 
artefact (designated 0 in Fig. 2) and onset of the first wave (A in Fig. 2). Duration of the EP 
was calculated as the difference of the 0-D and 0-A times. In case of the visual and auditory 
EPs, onset latency and duration was measured, in the same way. The tail nerve action 
potential had also a biphasic shape. There, onset latency was defined analogously with the 0-A 
distance. Tail nerve conduction velocity was calculated from the onset latency and the 
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distance of the electrodes. From double-pulse stimulation of the tail nerve, relative refractory 
period was determined. 
 
 
2.5. General toxicological investigations 
 
Beyond body weight and clinical observation mentioned above, organ weights were also used 
as indicators of general toxicity. Following electrophysiological recording, the animals were 
sacrificed by an overdose of urethane, and were dissected. Organs – brain, liver, lungs, heart, 
kidneys, spleen, thymus and adrenals – were removed and weighed. Relative organ weights, 
on the basis of 1/100 of body weight or brain weight, were calculated. 
 
2.6. Statistical analysis of the data 
 
From the general toxicological, behavioral and electrophysiological data, group means (±SD) 
were calculated. All results were checked for normality by means of the Kolmogorov-
Smirnov test, then tested for significance using one-way ANOVA with post hoc Scheffe’s test 
by the SPSS 15.0 for Windows software package. Significance was accepted at p<0.05. 
 
During the whole study, the principles of the Ethical Committee for the Protection of Animals 
in Research of the University were strictly followed. The methods used in the experiments 
were licensed by the authority competent in animal welfare issues under No. 
XXI./02039/001/2006.  
 
0
A
B
C
D
10 ms
2 mV
 
Figure 2. Typical example of the somatosensory evoked potential with the specific measuring 
points. See text for details. 
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3. RESULTS 
 
3.1. Effects of manganese 
 
3.1.1. Body and organ weights 
Oral Mn treatment had no effect on the time course of the body weight in 3 weeks, and had a 
slight effect in 6 weeks treatment (Fig. 3). But, as soon as intratracheal administration of Mn 
NPs started (4th and 7th week, respectively), the weight gain in the treated groups got 
substantially slower than either in the untreated (MnC) or in the vehicle-treated (MnVC) 
control. 
 
Body weight gain over the entire treatment period (the 3, 6 or 12 weeks), shown in Table 3, 
was significantly reduced vs. control mostly in groups with combined treatment. These data 
indicate also that the procedure of it. administration in itself had minimal effect. The groups 
MnL6 and MnH6, and MnL33 and MnH33, received Mn for equally long treatment periods 
but in different chemical form and amount. By plotting the calculated daily weight gain 
against the total applied Mn amount (calculated summed dose in Table 3) for each animal in 
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Figure 3  Time course of the control and treated rats’ body weight over the 3, 6 and 12 weeks of Mn 
exposure. Mean values, n=8. Error bars are omitted for clarity. 
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the relevant groups (Fig. 4) one can see that the weight gain in rats with combined, po. + it., 
treatment was mostly less than in the comparable only-po. group, though the total amount of 
Mn administered was lower.  
 
Table 3  Body weight gain over the 3, 6 and 12 weeks of Mn exposure, and summed Mn 
dose calculated for the same periods. 
 Groups 
 MnC3 MnVC3 MnL3 MnH3 
Body weight gain (g) 161.67±14.45 149.80±11.21 149.17±13.85 143.71±23.61 
Calculated summed dose 
(mg Mn/rat) -- -- 17.94±0.51 71.58±2.93 
 MnC33 MnVC33 MnL33 MnH33 
Body weight gain (g) 234.17±19.68 218.44±20.95 210.89±17.18* 195.20±27.60**# 
Calculated summed dose 
(mg Mn/rat)      28.46±0.55    83.42±2.95 
 MnC6 MnVC6 MnL6 MnH6 
Body weight gain (g) 234.18±29.09 235.17±15.26 226.14±17.30 211.00±19.28# 
Calculated summed dose 
(mg Mn/rat)   44.55±1.00    178.43±8.53 
 MnC66 MnVC66 MnL66 MnH66 
Body weight gain (g) 303.67±36.31 281.25±43.16 267.57±22.77* 251.88±23.62* 
Calculated summed dose 
(mg Mn/rat)      67.14±5.21   201.73±7.51 
Mean±SD, n=8. 
*, **: p<0.05, 0.01 vs. VC, #: p<0.05 MnH vs. MnL. 
The summed dose was calculated by adding individual daily doses which were calculated on the basis 
of daily body weights. 
 
4
4,5
5
5,5
6
6,5
0 20 40 60 80 100 120 140 160 180 200
Summed Mn dose, mg
Weight gain per day, 
g
Low po. dose, 3+3
Low po. dose, 6
High po. dose, 3+3
High po. dose, 6
 
 
Figure 4  Calculated daily weight gain (total weight gain divided by the length of treatment period) 
of the individual rats plotted against their calculated summed Mn dose. 
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Among the relative organ weights, that of the lung, liver and adrenals showed significant 
changes (Table 4; the table also lists the absolute data of brain weight to show the basis of 
calculation). Lung weight was strongly affected by the it. Mn treatment (MnL33, MnH33) 
and less strongly also by the it. vehicle administration (MnVC33). The lungs excised from 
rats with it. Mn exposure had typically an emphysematic appearance with visible dark spots of 
Mn deposition. 
 
Table 4  Relative organ weights of the lungs, liver and adrenals, and the absolute brain 
weights used as calculation basis. 
 Relative organ weights 
Groups 
Brain absolute 
weight (g) 
Lungs Liver Adrenals 
MnC3 1.989±0.061 0,170±0.009 1,856±0.104 0,0070±0.0010 
MnVC3 1,999±0.072 0,200±0.021* 1,606±0.103* 0,0085±0.0027 
MnL3 2,038±0.095 0,167±0.017# 1,837±0.207# 0,0070±0.0008 
MnH3 1,974±0.111 0,224±0.055*X 1,840±0.299 0,0081±0.0011X 
MnC33 2,076±0.061 0,169±0.020 1,534±0.101 0,0061±0.0013 
MnVC33 2,092±0.067 0,214±0.009** 1,563±0.113 0,0062±0.0007 
MnL33 2,053±0.043 0,391±0.056***### 1,626±0.133 0,0078±0.0014*# 
MnH33 2,106±0.077 0,372±0.018***### 1,450±0.075#X 0,0073±0.0014* 
MnC6 2,127±0.047 0,151±0.013 1,512±0.102 0,0057±0.0006 
MnVC6 2,092±0.028 0,154±0.013 1,443±0.088 0,0064±0.0014 
MnL6 2,124±0.076 0,149±0.011 1,546±0.081 0,0070±0.0009* 
MnH6 2,103±0.060 0,165±0.022 1,430±0.106 0,0063±0.0008 
MnC66 2.117±0.106 0.134±0.013 1.283±0.124 0.0057±0.0007 
MnVC66 2.157±0.081 0.264±0.016 1.240±0.126 0.0055±0.0011 
MnL66 2.160±0.138 0.431±0.027***### 1.459±0.129* 0.0062±0.0014* 
MnH66 2.095±0.132 0.451±0.045***### 1.235±0.106 0.0062±0.0016* 
For group codes, see Table 1; for the calculation, see Methods. The data are mean±SD (n=8). 
*, **, ***: p<0.05, 0.01, 0.001 vs. C; #, ### p<0.05, 0.001 vs. VC; X: p<0.05 MnH vs. MnL 
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3.1.2. Open field motility 
 
Mn treated rats showed decreased motility only after 6 and 6+6 weeks exposure; the effect 
after 3 and 3+3 weeks was absent or minimal (not shown). As seen in Table 5, 6 weeks po. 
treatment caused some decrease in motility but this was rarely significant. After 6 weeks po. + 
6 weeks it. exposure, high dose caused significant decrease in ambulation time and count, and 
increase in the time of local activity and immobility. The length of individual events of local 
activity and immobility also increased in MnH66. 
 
Table 5  Data of open field motility in rats treated with Mn by the 6 and 6+6 weeks 
scheme and the corresponding controls. 
A. 6 weeks oral exposure. 
Groups MnC6 MnVC6 MnL6 MnH6 
Ambulation distance (cm) 2230.45±266.45 2543.38±309.44 2293.59±372.49  2255.68±415.08 
Ambulation time (s)   255.33±7.87   298.33±13.29   268.88±25.54#    253.88±32.24# 
Ambulation count     37.17±5.78     32.50±3.02     33.25±4.74      33.75±5.20 
  Ambulation speed (cm/s)       8.76±1.19       8.50±0.70       9.02±0.99        9.03±1.13 
  Ambulation time/count (s)       7.02±1.16       9.25±0.95       7.88±1.64        8.32±1.87 
Local activity time (s)   113.17±18.55   116.67±14.62   115.50±34.32    112.75±30.77 
Local activity count     55.00±5.14     52.33±6.02     57.88±12.38      50.50±10.70 
  Local activity time/count (s)       2.05±0.24       2.24±0.32       2.15±0.23        2.21±0.25 
Immobility time (s)     14.83±6.01     18.17±7.70     20.25±15.87      13.50±7.91 
Immobility count       9.83±3.19     10.67±4.68     13.00±8.00        9.13±4.09 
  Immobility time/count (s)       1.52±0.38       1.91±0.94       1.47±0.30        1.44±0.29 
Rearing time (s)   217.67±23.47   167.83±23.02   196.38±32.64    200.88±35.56 
Rearing count     82.67±16.03     65.00±10.94     70.75±13.31      73.75±9.18 
  Rearing time/count (s)       2.72±0.59       2.60±0.26       2.81±0.44        2.72±0.30 
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B. 6 weeks oral + 6 weeks intratracheal exposure 
Groups MnC66 MnVC66 MnL66 MnH66 
Ambulation distance (cm) 1741.82±650.61 2184.59±469.23 1610.48±355.60# 1631.40±234.60# 
Ambulation time (s)   248.67±71.11   264.13±33.27   245.20±32.55   222.50±22.88# 
Ambulation count     33.00±6.63     32.63±4.81     30.90±4.61      31.00±3.30 
  Ambulation speed (cm/s)       6.81±1.38       7.81±0.85       7.32±0.66        6.89±0.85 
  Ambulation time/count (s)      7. 86±3.02       8.29±1.89       7.42±1.43        8.23±1.11* 
Local activity time (s)   154.17±80.23   137.38±26.60   168.40±29.95##    177.90±24.04*## 
Local activity count     66.33±21.77     60.25±8.26     70.90±11.59      69.60±9.97 
  Local activity time/count (s)       2.22±0.44       2.28±0.28       2.39±0.28        2.56±0.55 
Immobility time (s)     27.67±22.05     19.13±9.52     36.38±18.24*##      34.50±13.63*# 
Immobility count     16.17±10.01     12.25±5.52     23.60±12.08#      16.80±4.42 
  Immobility time/count (s)       1.58±0.31       1.55±0.32       1.31±0.81        1.71±0.49 
Rearing time (s)   170.50±62.65   180.38±35.78    168.30±42.67    141.10±47.18# 
Rearing count     67.50±17.38     65.88±11.56      61.90±13.25      56.70±14.35*# 
  Rearing time/count (s)       2.48±0.57       2.78±0.60        2.72±0.42        2.45±0.43 
Mean+SD, n=8. 
*, **: p<0.05, 0.01 vs. C; #, ##: p<0.05, 0.01 vs. VC. 
 
3.1.3. Cortical electrical activity 
 
The general trend in the ECoG band spectra was a decrease in the delta, and increase in the 
theta and in the fast (beta, gamma) bands. Similarly to the OF effects, these changes were 
relatively more pronounced only after 6 and 6+6 weeks Mn treatment (Fig. 5). Data of the 
untreated controls are not displayed, in order to avoid crowded graphs and because the 
difference between MnC and MnVC was slight. 
The somatosensory EPs showed increased latency on the action of Mn. This increase was seen 
at all stimulation frequencies but the steepness of frequency dependence of the latency was 
not much altered by Mn. Fig. 6 shows latency data in relative values, normalized to the 
latency of the SS EP obtained with 1 Hz stimulation in the corresponding MnVC group. This 
kind of display was chosen in order to eliminate the differences between control values in the 
various treatment schemes and so to bring the effect of Mn dose and of treatment scheme in 
the foreground. The SS latency lengthening was of similar magnitude in MnL33 and MnL6 
(and was only slightly more different in MnH33 vs. MnH6) in spite of the dissimilar summed 
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dose (see Table 3) which was approximately in accordance with the relationship of summed 
Mn dose and body weight. VIS latency in the groups MnH33 and MnH6 was in similar 
relationship (Fig. 7). AUD latencies changed less consequently. 
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Figure 5  Band spectrum of the ECoG in rats treated with Mn by the 6 and 6+6 weeks scheme. 
*: p<0.05 vs. MnVC; #: p<0.05 high vs. low dose. 
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Figure 6  Latency of the somatosensory EP in rats treated with Mn according to the various 
schemes (top: 3 and 3+3, bottom: 6 an 6+6 weeks). Relative values, normalized to the latency of the 
SS EP obtained with 1 Hz stimulation in the corresponding MnVC group. Mean+SD, n=8. 
*,**,***: p<0.05, 0.01, 0.001 vs. MnVC, at identical stimulation frequency (see insert) 
°,°°,°°°: p<0., .01, 0.001 vs. latency with 1 Hz stimulation within a treatment group 
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Figure 7  Latency of the visual and auditory EPs in rats treated with Mn according to the various 
schemes. Relative values, normalized to the latency in the corresponding MnVC group. 
Mean+SD, n=8. 
*,**,***: p<0.05, 0.01, 0.001 vs. MnVC 
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3.1.4. Tail nerve action potential 
 
Conduction velocity in the tail nerve was significantly decreased by Mn treatment (Fig. 8, 
top), even at the lowest dose applied (that is, in MnL3). Beyond the general dose dependence, 
the velocity reduction in MnL33 and MnH33 was again stronger or ca. equal to that in MnL6 
and MnH6, respectively – similarly to the case of the SS EP. Relative refractory period, 
which characterizes the frequency following ability of the nerve (Fig. 8, bottom), increased 
with a roughly similar dependence on the dose as the conduction velocity did. 
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Figure 8  Conduction velocity (top) and relative refractory period (bottom) in rats treated with Mn 
according to the various schemes. Mean+SD, n=8. Relative values were normalized to the value 
measured in the corresponding VC group.  
*,**,***: p<0.05, 0.01, 0.001 vs. corresponding VC. 
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3.2. Effects of lead 
 
3.2.1. Body and organ weights 
 
The effect of Pb administration on the body weight gain was visible already after 3 weeks po. 
treatment, but only with the high dose (Fig. 9). Starting the it. administration of Pb NPs (3+3, 
6+6 weeks treatment) caused a marked drop in the weight gain, both after the high and low 
po. dose. This is reflected also in the weight gain data in Table 6, where the weight gain 
reduction was significant also in PbH3 and PbH6. The relationship between weight gain and 
summed dose (Fig. 10) was dissimilar to that seen with Mn in Fig 4, and indicated a 
dependence of the weight gain more on the summed dose – which was ca. the twofold in 6 
weeks po. treatment compared to that in 3 weeks po. + 3 weeks it. (see Table 6) – and less on 
the physicochemical form of Pb. 
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Figure 9  Time course of the control and treated rats’ body weight over the 3, 6 and 12 weeks of Pb 
exposure. Mean values, n=8. Error bars are omitted for clarity. 
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Table 6  Body weight gain over the 3, 6 and 12 weeks of Pb exposure, and summed Pb 
dose calculated for the same periods. 
 Groups 
 PbC3 PbVC3 PbL3 PbH3 
Body weight gain (g) 112.17±14.29 111.67±11.00 108.33±12.03   78.00±8.77**X# 
Calculated summed 
dose (mg Pb/rat) -- -- 193.98±9.67 710.29±50.55 
 PbC33 PbVC33 PbL33 PbH33 
Body weight gain (g) 185.17±25.87 166.33±12.01 170.13±17.29 144.57±25.57 
Calculated summed 
dose (mg Pb/rat)   219.43±8.62 796.41±57.81 
 PbC6 PbVC6 PbL6 PbH6 
Body weight gain (g) 172.33±31.99 160.60±16.41 164.17±13.47   127.50±23.42*# 
Calculated summed 
dose (mg Pb/rat)   450.58±17.32 1675.23±67.67 
 PbC66 PbVC66 PbL66 PbH66 
Body weight gain (g) 240.67±35.56 251.33±22.98 212.22±25.83#   195.38±25.12**X 
Calculated summed 
dose (mg Pb/rat)   499.58±25.70 1819.80±83.51 
Mean±SD, n=8.  
*,**: p<0.05, 0.01 vs. PbC; #: p<0.5 vs. PbVC; X: p<0.05 high vs. low dose. 
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Figure 10  Calculated daily weight gain of the individual rats plotted against their calculated summed 
Pb dose. Displayed as in Fig. 4 
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The relative weight of the lungs increased massively in all groups with it. Pb administration, 
and less strongly also in the corresponding vehicle controls (Table 7). In the groups receiving 
the highest summed dose (PbH3, PbH33, PbH6, PbL66, PbH66) kidney weight increased 
significantly. Femur weight had a decreasing trend but without significance, a similar trend in 
the liver weight was not clearly present. 
 
Table 7  Relative organ weights of the lungs, liver and adrenals, and the absolute brain 
weights used as calculation basis. 
 Relative orghan weights 
Groups 
Brain 
absolute 
weight (g) Lungs Liver Kidney Femur 
PbC3 2.03±0.13    0.64±0.10 6.19±0.54  1.31±0.11 0.42±0.04 
PbVC3 2.09±0.06    0.65±0.04 6.02±0.94  1.18±0.04 0.41±0.06 
PbL3 2.03±0.08    0.67±0.07 6.20±0.58  1.24±0.07    0.36±0.02 * 
PbH3 1.98±0.09 #    0.68±0.06 5.92±0.47 1.36±0.19 # 0.38±0.04 
PbC33 2.18±0.08    0.96±0.24 6.11±0.81   1.34±0.14 0.49±0.07 
PbVC33 2.05±0.08    1.21±0.29 6.42±1.01   1.43±0.12 0.51±0.07 
PbL33 2.15±0.04 2.52±0.30***### 7.14±0.51*   1.50±0.10 0.50±0.02 
PbH33   2.05±0.13 * 2.38±0.32 ***### 6.11±0.20x 1.54±0.18* 0.49±0.09 
PbC6 2.05±0.08   0.85±0.26 7.84±2.89   1.77±0.59 0.60±0.23 
PbVC6 1.83±0.37   0.67±0.07 6.19±0.87   1.29±0.18 0.48±0.03 
PbL6 2.04±0.03   0.85±0.27 6.69±0.62   1.51±0.15 0.51±0.04 
PbH6 1.97±0.11   0.81±0.12 6.81±0.54  1.76±0.46 # 0.51±0.06 
PbC66 2.03±0.06   0.71±0.11 6.79±0.63   1.46±0.10 0.64±0.05 
PbVC66 2.15±0.08   1.42±0.11** 6.63±0.90   1.32±0.16 0.61±0.05 
PbL66 2.08±0.08 2.87±0.35 ***### 7.51±1.22  1.59±0.16 ## 0.61±0.06 
PbH66   2.06±0.07 # 3.02±0.56 ***### 6.98±0.83  1.63±0.12*## 0.57±0.07 
Mean+SD, n=8. 
*, **, ***: p<0.05, 0.01, 0.001 vs. C; #, ##, ###: p<0.05, 0.01, 0.001  vs. VC 
X
 : p<0.05 PbL3 vs PbH3 
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3.2.2. Open field motility 
 
Pb-treated rats spent more time with ambulation and covered longer paths. The speed of 
movement was not changed (or was even reduced in PbH66) but single events of walking 
lasted longer (Table 8). There was also some increase in the time spent in local activity and 
such events were significantly longer also in PbH66. Rearing was significantly reduced in the 
treated rats, and these also spent more time in immobility.  
 
Table 8  Data of open field motility in rats treated with Pb by the 6 and 6+6 weeks 
scheme and the corresponding controls. 
A. 6 weeks oral exposure. 
Groups PbC6 PbVC6 PbL6 PbH6 
Ambulation distance (cm) 2259.85±308.11 2532.42 ±228.02 2341.86±126.77 2495.10±282.65 
Ambulation time (s)   262.67±19.04   284.60±12.46   284.40±24.54   298.75±28.94* 
Ambulation count     33.83±4.17     37.20±6.22     34.60±4.83     29.25±5.56# 
  Ambulation speed (cm/s)       8.58±0.78       8.89±0.56       8.26±0.51       8.36±0.50 
  Ambulation time/count (s)       7.89±1.41       7.80±1.16       8.42±1.89     10.60±2.81*# 
Local activity time (s)   112.83±11.91   107.20±45.25   100.17±18.32   124.25±11.06 
Local activity count     52.33±6.09     48.80±11.43     49.83±3.87 
    60.25±1.89*x 
  Local activity time/count (s)       2.16±0.19       2.13±0.50       2.00±0.24       2.06±0.21 
Immobility time (s)     19.83±8.95     14.20±9.98     18.00±12.20     20.25±7.85 
Immobility count     14.17±5.64       9.60±5.77     11.33±5.47     12.50±5.07 
  Immobility time/count (s)       1.37±0.19       1.42±0.31       1.49±0.29       1.63±0.16 
Rearing time (s)   205.67±27.03   195.00±46.07   202.33±25.77   157.75±31.64* 
Rearing count     60.83±6.34     76.20±14.58     77.33±11.52     76.75±9.22* 
  Rearing time/count (s)       3.42±0.64       2.55±0.29       2.64±0.25 
      2.05±0.23 **x 
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B. 6 weeks oral + 6 weeks intratracheal exposure. 
Groups PbC66 PbVC66 PbL66 PbH66 
Ambulation distance (cm) 2171.78±386.72 2058.16±451.43 2027.28±55.14     2241±138.47 
Ambulation time (s)   261.50±28.79   252.83±44.02   279.17±21.94  313.17±22.12**## 
Ambulation count     31.83±3.66     31.17±2.71     32.67±4.13    24.00±3.58 **##xx 
  Ambulation speed (cm/s)       8.27±0.87       7.66±0.83       6.16±3.11      7.31±0.19 ***### 
  Ambulation time/count (s)       8.29±1.27       8.18±1.75       8.71±1.63     13.36±2.64 xxx 
Local activity time (s)   127.50±41.26   139.83±54.76   150.00±16.53   161.83±13.99 
Local activity count     64.67±11.78     64.17±13.79     62.50±5.36     68.33±4.03 
  Local activity time/count (s)       1.94±0.36       2.12±0.41       2.40±0.17       2.38±0.27*# 
Immobility time (s)     19.83±9.87     24.50±12.83     18.83±7.36     24.83±11.27 
Immobility count     13.83±5.91     14.83±6.21     12.83±4.71     14.00±4.05 
  Immobility time/count (s)       1.39±0.15       1.61±0.27       1.47±0.29       1.72±0.43***### 
Rearing time (s)   192.17±38.00   183.83±30.36   153.00±29.50   101.17±30.41 x 
Rearing count     79.67±16.45     69.83±9.77     64.33±9.14     48.17±10.15***##x 
  Rearing time/count (s)       2.44±0.40       2.63±0.22       2.39±0.39       2.07±0.27## 
Mean+SD, n=8. 
*, **, ***: p<0.05, 0.01, 0.001 vs. C; #, ##, ###: p<0.05, 0.01, 0.001  vs. VC 
X: p<0.05 high vs. low dose 
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3.2.3. Cortical electrical activity 
 
After 3 and 3+3 weeks, there were no noteworthy changes in the band spectrum of the ECoG 
(not shown). In the groups PbL6 and PbH6, increased slow and decreased fast activity was 
seen, compared to their control PbVC6. However, in the rats receiving 6 weeks it. Pb 
exposure after 6 weeks po. treatment, this frequency shift disappeared (Fig. 11). 
 
Latency of the SS EP was increased in the Pb-treated rats (Fig. 12). The change was 
significant vs. vehicle control in rats with 3+3, 6 and 6+6 weeks treatment. The change in 
PbH33 and PbH6 was nearly equal, and in PbL33 was somewhat bigger than in PbL6. 
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Figure 11  Band spectrum of the ECoG in rats treated with Pb by the 6 and 6+6 weeks scheme. 
*,**: p<0.05, 0.0 vs. PbVC. 
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Figure 12  Latency of the somatosensory EP in rats treated with Pb according to the various 
schemes. Relative values, normalized to the latency of the SS EP obtained with 1 Hz stimulation in 
the corresponding PbVC group. Mean+SD, n=8. 
*,**,***: p<0.05, 0.01, 0.001 vs. PbVC, at identical stimulation frequency (see insert). 
°,°°: p<0.05, 0.01 vs. latency with 1 Hz stimulation within a treatment group. 
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Figure 13  Latency of the visual and auditory EPs in rats treated with Pb according to the various 
schemes. Relative values, normalized to the latency in the corresponding PbVC group. Mean+SD, 
n=8. *,**,***: p<0.05, 0.01, 0.001 vs. PbVC 
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In both combination groups, the frequency dependent lengthening of the latency became also 
more intense. The relationship of latencies in PbH33 and PbH6 was dissimilar to that of body 
weight gain in these groups (Fig. 12). Also in the VIS EP, the latency in PbH33 and PbH6 
was nearly equal. The latency of AUD EP was also lengthened but in a rather irregular way 
(Fig. 13). 
 
3.2.4. Tail nerve action potential 
 
Conduction velocity in the tail nerve was generally decreased in the Pb-treated rats (Fig. 14). 
Again it seemed that, as in the case of weight gain, the change reflected more the dose and 
less the chemical form of Pb. The length of relative refractory period showed some changes 
but no clear tread (not shown). 
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Figure 14  Conduction velocity in rats treated with Pb according to the various schemes. 
Mean+SD, n=8. Relative values were normalized to the value measured in the corresponding VC 
group.  
*,**,***: p<0.05, 0.01, 0.001 vs. corresponding VC 
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3.3. Effects of cadmium 
 
3.3.1. Body and organ weights 
 
The time course of the body weight was markedly different in the groups Cd13 and Cd31, 
and suggested that the NP form of Cd had, in spite of the much lower dose, more pronounced 
effect on this toxicological parameter (Fig. 15; Cd3 and CdV3 are not included because these 
are practically identical to the first 3 weeks of Cd31 and CdV31). The effect is also seen in 
the weight gain and Cd dose data given separately for the po. and it. administration weeks in 
Table 9.  
 
 
 
Table 9  Body weight gain and summed Cd doses in the oral and intratracheal treatment 
periods. 
Groups Body weight gain (g) 
Calculated 
summed dose 
(mg Cd/rat) 
Body weight gain 
(g) 
Calculated 
summed dose 
(mg Cd/rat) 
 Week 1 - 3 Week 4 
CdV31 120.50±15.66 --   21.33±4.89 -- 
Cd31   80.38±35.58* 8.603±0.269 -27.14±24.07*** 0.042±0.003 
 
 Week 1 Week 2 - 4 
CdV13   11.67±6.65    97.67±26.09  
Cd13 -37.86±13.52*** 0.032±0.004 138.51±19.57* 6.425±0.589 
Mean+SD, n=8. *,***: p<0.05, 0.001 vs. corresponding control. 
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Figure 15  Time course of the control and treated rats’ body weight treated by the 1+3 and 3+1 
schemes (see Table 8). Mean values, n=8. Error bars are omitted for clarity. 
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The relative weight of the lungs was massively influenced by the it. application (Table 9). 
Weight decrease of the liver and kidneys was also significant only in the combined treatment 
groups, and was strongest in Cd31, suggesting a disproportionately high toxicity of 
nanoparticulate Cd. 
 
Table 10  Relative organ weights of the lungs, liver and adrenals, and the absolute brain 
weights used as calculation basis 
 Relative organ weights 
Groups 
Brain absolute 
weight (g) 
Lungs Liver Kidneys 
CdV3 2.093±0.059 0.650±0.036 6.025±0.940 1.181±0.042 
Cd3 2.022±0.074 0.655±0.047 5.697±0.345 1.199±0.084 
CdV31 2.064±0.061 0.908±0.051 7.238±0.569 1.387±0.074 
Cd31 1.997±0.086       1.615±0.220***   5.910±1.233*     1.153±0.133** 
CdV13 1.918±0.186        0.940±0.095 6.521±0.222 1.353±0.089 
Cd13 1.976±0.118     1.338±0.162** 6.254±0.647   1.191±0.077* 
Mean+SD, n=8. 
*,**,***: p<0.05, 0.01, 0.001 vs. corresponding control. 
 
3.3.2. Open field motility 
 
Decreased motility was observed in all Cd-treated rats vs. the corresponding controls. In Cd3, 
only the run length was reduced; but in Cd31, nearly all parameters were altered including 
slower ambulation speed and longer events of local activity and immobility. In Cd13 the 
changes were similar but less strong and mostly not significant. The data are shown in Table 
11. 
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Table 11  Data of open field motility in rats treated with Cd by the various treatment 
schemes. 
A. 3 weeks oral exposure. 
Groups CdC3  CdV3 Cd3 
Ambulation distance (cm) 2848.64±175.82 2631.98±585.19 2420.33±201.35 *xxx 
Ambulation time (s) 324.00±45.40 289.33±61.72    292.67±18.38 xxx 
Ambulation count 26.00±6.36    32.00±10.00      27.33±4.23 
  Ambulation speed (cm/s)   8.46±0.63    9.11±1.10        8.28±0.64 xx 
  Ambulation time/count (s) 13.53±5.31  10.60±6.83      11.00±2.37 
Local activity time (s) 129.33±30.47  115.33±43.03    144.67±25.52 xxx 
Local activity count   58.50±11.48    50.17±12.66      61.83±6.68 #xx 
  Local activity time/count (s)  2.22±0.33    2.26±0.47        2.33±0.23 xx 
Immobility time (s)  26.33±11.84    16.00±13.97      25.83±6.62 xx 
Immobility count           16.00±5.69  10.33±6.47      14.50±3.27 xxx 
  Immobility time/count (s) 1.67±0.39    1.41±0.29        1.82±0.50 x 
Rearing time (s)         121.33±35.59  180.33±69.88    137.83±36.27 xx 
Rearing count 57.00±15.26    65.17±19.21      57.67±17.96 xx 
  Rearing time/count (s) 2.13±0.39    2.72±0.62        2.42±0.35 
B. Combined exposures  
Groups CdV31  Cd31 CdV13 Cd13 
Ambulation distance (cm) 2493.07±289.12    392.38±358.48 ###       2705.97±108.61    2226.76±363.10 #ooo 
Ambulation time (s)   290.67±26.27 210.17±44.83 ##         297.17±21.84      265.86±19.39 o 
Ambulation count     29.33±2.07   26.67±6.35            30.67±1.63        31.43±4.43 
  Ambulation speed (cm/s)       8.59±0.91     6.58±0.43 ###             9.15±0.77          8.34±0.81 ooo 
  Ambulation time/count (s)      9.95±1.14     8.24±2.71             9.73±1.10           8.59±1.21 
Local activity time (s)  146.50±33.64 241.00±34.30 ###         129.83±33.62       156.14±37.65 ooo 
Local activity count    61.17±9.99   81.50±8.87 ##           53.00±8.20         65.86±9.60  #oo 
  Local activity time/count (s)      2.39±0.40     2.96±0.29 #              2.44±0.50           2.37±0.38 oo 
Immobility time (s)    17.50±5.24   87.00±52.22  ###            15.33±6.92         18.71±8.71 ooo 
Immobility count    12.00±2.28   34.17±13.44 ###            11.67±3.83         13.29±4.89 ooo 
  Immobility time/count (s)     1.44±0.21     2.41±0.67 ###              1.29±0.26           1.40±0.21 ooo 
Rearing time (s) 146.33±23.64   62.83±42.96 ##          158.67±41.35        160.29±41.01 ooo 
Rearing count   69.17±11.62   26.67±12.04 ###            70.67±12.97          61.71±17.16 ooo 
  Rearing time/count (s)     2.13±0.27     2.20±0.71              2.23±0.22            2.65±0.58 
*: p<0,05  CdC3 vs. Cd3 
#, ##, ###: p<0.05, 0.01, 0.001 CdV31 vs. Cd31 or CdV13 vs. Cd13 
x, xx, xxx: p<0.05, 0.01, 0.001 Cd31 vs. Cd3 
o, oo, ooo: p<0.05, 0.01, 0.001  Cd31 vs. Cd13 
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3.3.3. Cortical electrical activity 
 
In the band spectrum of the ECoG, there was practically no change in any of the Cd-treated 
groups. 
In the somatosensory EP, increase of the latency was seen in all treated groups. In Cd31, the 
increase was significant at all stimulation frequencies (1, 2 and 10 Hz) vs. CdV31; whereas in 
the other treatment schemes (Cd3, Cd13) only at the highest stimulation frequency (Fig.16, 
top). The body weight gain difference was also the highest in Cd31 vs. CdV31 around the 
time of electrophysiological recording. The frequency-dependent extra lengthening of latency 
was, however, more pronounced also in Cd3 and in Cd31 than in the corresponding controls. 
The VIS and AUD EPs were also significantly lengthened by Cd application in the groups 
Cd3 and Cd31, but not in Cd13 (Fig. 16, bottom). 
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Figure 16  Latency of the somatosensory EP (top) and visual and auditory EP (bottom) in rats 
treated with Cd according to the various schemes. Relative values, normalized to the latency of 
the EP in the corresponding control group (for SS: with 1 Hz stimulation). Mean+SD, n=8. 
*,**: p<0.05, 0.01 vs. control (V) at identical stimulation frequency (see insert). 
°,°°,°°°: p<0.05, 0.01, 0.001 vs. latency with 1 Hz stimulation within a treatment group. 
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3.3.4. Tail nerve action potential 
 
 
Decreased conduction velocity of the tail nerve was found in all treated groups (Fig. 17) but 
here there was no difference between various treatments, unlike what was seen in the cortical 
evoked responses. The lengthening of the relative refractory period, which indicated increased 
fatigability of the nerve in the treated rats, was significant in Cd3 and Cd13. 
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Figure 17  Conduction velocity (top) and relative refractory period (bottom) in rats treated with 
Mn according to the various schemes. Mean+SD, n=8. Relative values were normalized to value 
measured in the corresponding VC group.  
*,**,***: p<0.05, 0.01, 0.001 vs. corresponding VC. 
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4. DISCUSSION 
 
In evaluation of toxicological results obtained in an animal model, one of the main questions 
is to what extent the doses used correspond to those observed in cases of human exposure. 
Reported high Mn levels in drinking water were ca. 50 µg/L in Greece (Kondakis et al., 1989) 
or even above 1000 µg/L in Bangla Desh (Wassermann et al., 2006). From the latter data and 
2 L of water consumed a day, the daily dose for an adult would be ca. 0.03 mg/kg Mn. Our 
doses were in fact much higher, but the resulting blood level in a previous experiment with 
the same doses (Vezér et al., 2005) was ca. 36 µg/L blood, in the same order of magnitude 
with Mn blood levels of heavily exposed workers (Halatek et al., 2005). 
If a daily ventilation volume of 0.5 m3/kg b.w. is supposed for the rats (based on 
physiological data by Strohl et al., 1997) the it. dose of 2.63 mg/kg MnO2 NPs corresponds to 
ca. 1.7 mg/m3 in continuous exposure (or three times that for 8 hours per day). In heavily 
polluted workplace atmospheres, ca. 0.8 mg/m3 (Bader et al., 1999) was described as human 
exposure. 
The dose for it. application of Pb was originally derived from papers by Coffigny et al. (1994) 
and Pinon-Lataillade et al. (1993) who obtained 500-700 µg/L blood Pb levels in rats by 
continuous exposure to air containing 5 mg/m3 lead oxide dust. This external dose 
corresponds to ca. 2.5 mg/kg b.w. per day if a daily ventilation volume of 0.5 m3/kg b.w. is 
supposed again. So, 2 mg/kg dose was chosen, which previously resulted in ca. 1700 µg/L 
blood levels (Oszlánczi et al., 2011). In actual industrial exposures, airborne Pb levels lower 
than 5 mg/m3 also caused similar blood levels: 1.06 mg/m3 Pb in fumes (probably including 
NPs) in a lead battery workshop and 635 µg/L Pb in the exposed workers’ blood (controls: 87 
µg/L; Jiang et al., 2008); or 0.6 mg/m3 Pb in another lead battery plant, and up to 500 µg/L Pb 
in the exposed workers’ blood (Lormphongs et al., 2004). The po. Pb doses are hard to bring 
into direct human analogy because oral exposure to Pb, if any, typically comes from several 
sources. Anyway, in an earlier study with 10 weeks oral exposure of rats to 500 mg/kg b.w. 
Pb-acetate, 2500 µg/L blood level was obtained (Vezér, unpublished). The lower doses used 
in the present work (80 and 320 mg/kg) probably resulted in blood levels nearer to those 
found in exposed humans. 
In the case of Cd exposure, our intratracheal dose (0.04 mg/kg b.w.) is somewhat above those 
found in industrial settings; based on the daily ventilation volume of rats mentioned above. 
Measured airborne levels were ca. 30 µg/m3 (indoors in car body repair shops; Vitayavirasuk 
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et al., 2005) or 1-19 µg/m3 (outdoors, in bridge maintenance; Conroy et al., 1995). However, 
in a rat inhalation experiment 70 and 550 µg/m3 were used (Takenaka et al., 2004). 
Both the general and functional neurotoxicological parameters indicated several times during 
the experiments described in this thesis that there can be a non-additive interaction between 
the amounts of heavy metals given by po. and it. application.  
The toxic effects of Cd were mostly stronger in the combination groups (Cd13 and Cd31) 
than in the group treated with oral Cd only (Cd3); exemplified both by body weight gain and 
SS EP latency (Fig. 15,16). In Cd31, where the rats received 3 weeks oral then 1 week 
intratracheal exposure, the amount of Cd given it. was much less than that given po. 
previously, yet the final effect suggested potentiating interaction. During the 3 weeks of oral 
Cd treatment, the blood-brain barrier (BBB) may have been weakened (as described by 
Shukla et al., 1996), so the Cd-containing NPs applied afterwards had higher chance to enter 
the brain. A potentiation-like effect was also seen in the time course of the body weight, and 
in the relative liver weight. In an experiment with 6 weeks intratracheal application of CdO2 
NPs, a tenfold dose (0.4 mg/kg) was needed to achieve significant CNS effects (Papp et al., 
2009) which is another argument for the potentiating interaction. 
Pb is another metal known to affect BBB (Goldstein et al., 1974), which may explain that, 
among the Pb-treated rats, lengthening of SS EP latency was nearly equal in PbH33 and 
PbH6, despite the ca. twice higher summed dose in the 6 weeks po. Pb administration. 
In the experiment with Mn and with Cd (but not with Pb), the disproportionately strong effect 
of NP exposure was seen also on the body weight gain, a general parameter entirely 
independent of the state of the BBB. Metal level data from previous experiments with the 
same doses and routes of application as used here (Mn: Oszlánczi et al., 2010b; Vezér et al., 
2005) favor the reasoning that inhaled NPs cause internal exposure more efficiently than 
ingested, dissolved metals. In the works referred to above, 9 weeks it. application of 5.26 
mg/kg b.w. of MnO2 NPs resulted in ca. 7000 µg/kg Mn in the treated rats’ brain while 60 
mg/kg MnCl2 applied orally for 10 weeks gave only ca. 290 µg/kg. It is an open question, to 
be settled in further experiments (by electron microscopy), whether NPs themselves appear in 
the brain and in other organs – due to their extreme mobility within the organism – or their 
metal content is dissolved and absorbed, inducing the known general and organ-specific toxic 
effects. 
When discussing toxicity of NPs, oxidative stress must not be forgotten. Lungs are affected 
the most directly, and welding fumes containing Mn and other metals were reported to cause 
oxidative stress and inflammation in the airways, with depletion of glutathione (McNeilly et 
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al., 2004). CdTe NPs (quantum dots) are cytotoxic (Zhang et al., 2007) and Cd increases 
oxidative stress by enzyme inhibition (Casalino et al., 2002). Metabolites indicating oxidative 
damage and induction of antioxidant enzymes upon Pb exposure were detected both in 
animals (Adonaylo and Oteiza, 1999) and in humans (Ahamed and Siddiqui, 2007). Even the 
reduced body weight gain observed in the treated animals might be due to oxidative stress, 
more exactly to the metabolic disturbance caused by the presence of free radicals (Merry, 
2002). Generation of reactive oxygen species was detected in the brain in case of all three 
metals, (Mn: Zhang et al., 2009; Cd: Kumar et al., 1996; Pb: Patra et al., 2001) resulting in 
membrane lipid peroxidation (Mn: Avila et al., 2008; Cd and Pb: Zanchi et al., 2010; Pb: 
Ahamed and Siddiqui, 2007). Damage to these important functional units of the cell 
membrane results in changes of fluidity and other membrane properties which, in turn, 
disturbs all membrane- and receptor-bound phenomena, such as synaptic transmission, and 
these are likely to be reflected e.g. in various forms of cortical activity. 
Cortical evoked potentials reflect alterations in synaptic transmission most directly. The 
increased latency observed in the rats treated with each of the metals might be, at least partly, 
due to decreased synaptic efficiency. Pb2+ ions block the voltage-gated Ca-channels in 
presynaptic endings, impeding this way intracellular Ca2+ rise and depolarization on arrival of 
an axonal discharge, and preventing synchronous emptying of vesicles. Inside, however, Pb2+ 
ions can activate a number of Ca-dependent processes including those involved in exocytosis, 
so the spontaneous release of the transmitter will be more likely; and the same has been 
reported also for Cd2+ ions (Suszkiw et al., 1984). For Mn2+, a similar mechanism (blocked 
membrane Ca-channels and increased intracellular Ca release at the same time) was reported 
by Kita et al. (1981). In rats exposed to traffic-generated dust containing Pb and Cd, short-
term memory was impaired (Zanchi et al., 2010), and memory formation and consolidation is 
known to depend on Ca-regulated neuronal events. 
The main excitatory transmitter in the CNS is glutamate. After being released into the 
synaptic cleft and having activated the receptors, glutamate is taken up and converted to 
glutamine by the astrocytes. Mn2+ decreases both the uptake (Erikson and Aschner, 2003) and 
the transformation to glutamine (Normandin and Hazell, 2001). The transporter (astrocytic 
GLT-1) is inhibited also by Pb2+ (Struzynska et al., 2005), and Cd2+ (Liu et al., 2008). Excess 
glutamate may desensitize the postsynaptic receptors leading to weaker and/or slower 
postsynaptic excitation, resulting in smaller/slower cortical evoked responses, and may also 
exert excitotoxicity (Coyle and Puttfarcken, 1993).  
  
59
The decrease of conduction velocity in the tail nerve was in line with the lengthened latency 
of the cortical EPs and was probably caused by the metal ions’ effect on the channels 
involved in action potential propagation and/or by energetic shortage due to mitochondrial 
inhibition. First of all the increased sensitivity to frequent stimulation, seen primarily on the 
somatosensory cortical EPs (increased difference between identical parameter of the response 
measured at 1 Hz vs. at much faster stimulation), suggested the latter. Mn is a well-
documented mitochondrial toxin, acting on complex II (Malecki, 2001) and complex III 
(Zhang et al., 2003). The mitochondrial damage by Pb was described by Lidsky and 
Schneider (2010). 
Energetic shortage could have a slowing effect on the basal cortical activity (ECoG) – 
similarly to cases of mitochondrial encephalopathy (Smith and Harding, 1993). Glutamatergic 
overactivity could have the opposite effect: glutamatergic collaterals from the specific 
afferents to the ascending reticular formation could increase cortical activity by cholinergic 
modulation (Metherate et al., 1992). The resulting net change may be (and in fact was) 
different depending on the relative strength of the two opposite influences. 
The changes in open field motor behavior may partly result from the general CNS effects of 
the metals/NPs but the dopaminergic system plays here the crucial role. Motivation, 
determining spontaneous open field locomotor activity, is regulated by 
mesolimbic/mesocortical dopaminergic structures (Alexander et al., 1990). Dopaminergic 
neurons are especially vulnerable to oxidative stress due to the auto-oxidizing tendency of 
dopamine and to the presence of monoamine oxidase producing hydrogen peroxide (Alexi et 
al., 2000). The tendency of Mn, Pb and Cd to induce oxidative stress is well known and was 
mentioned above as a common point in their effects on the nervous system. Of the activity 
forms measured, vertical motility is an specially sensitive indicator of striatal dopaminergic 
activity (Sedelis et al., 2001), and diminished rearing was observed in the rats exposed to Mn 
(Table 5) Pb (Table 8) and Cd (Table 11). Diminished horizontal movements after high dose 
Mn (MnH66) fits well in the picture of general hypomotility, a phenomenon possibly 
analogous to what has been described in welders suffering from the Mn-dependent Parkinson-
like syndrome (Bowler et al., 2006). The increased locomotion of the Pb-treated rats may be 
analogous to what was reported by Ma et al. (1999) in rats following Pb exposure during 
intra-and extrauterine development, and was explained by decreased cortical D2 receptor 
level. A possible human analog is “attention deficit hyperactivity disease” found more 
frequently among children with elevated blood Pb (Needleman and Gatsonis, 1990). Another 
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symptom reflecting impaired central motor control, postural sway, was also seen in Pb-
exposed workers (Yokoyama et al., 2002). 
 
Based on the results described and evaluated above, it can be stated that the attempt to model 
the complex exposure, coming both from environmental (food/waterborne) and occupational 
(inhalational) sources, was successful. In a world where the large-scale use of various metals 
is daily reality, where occupational exposure still endangers the workers’ health, and where 
emissions from present and past times can be found in the environment and in commodities of 
environmental origin – notably, drinking water and food – the health effects in general, and in 
particular the effects on sensitive systems like the nervous system, are of primary concern. 
The occurrence of metals in nanoparticulate form, let it be nanotechnological materials or 
unwanted pollutants, adds a new feature to the old problem. 
Especially when speaking of neurotoxicity, the study of functional alterations is important 
because by classical biomarkers – by detecting the levels of toxic metals in available human 
biological samples (blood or urine) – the damage to central or peripheral parts of the nervous 
system cannot be characterized adequately. This problem has been repeatedly raised in the 
literature (e.g. Manzo et al., 1996; Myers et al., 2003). Animal model experiments can 
contribute to the development of neuro-functional biomarkers which may be better suited for 
this purpose. 
 
The questions specified in Aims (1.6.) can finally be answered as follows: 
• The treatment schemes and doses used previously for oral and intratracheal application 
could be adapted without significant change in case of Mn and Pb treatment. In case of 
Cd, strong general toxicity required the development of a new scheme with shorter it. 
exposures. The doses, although caused comparable alterations in the 
electrophysiological (and partly in the behavioral) parameters, were at the systemic 
level not “equitoxic”. 
• In quantitative aspect it became clear that the NP form of the metals, applied after weeks 
of oral exposure to the dissolved form, had disproportionately strong effect on the 
body weight gain (Mn, Cd), as well as on some of the open field behavioral 
parameters and on parameters of evoked electrophysiological responses (all three 
metals). Qualitative difference was seen mainly in the electrocorticograms, which 
possibly reflected the interference of NP-specific (oxidative stress) and metal-specific 
(altered synaptic transmission etc.) actions. Comparison with earlier intratracheal-only 
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results also indicated that lower NP dose was enough to evoke the same effects when 
applied after oral treatment. 
• The differences in dose-response relationship could be examined only in terms of the 
external dose. Measurements of internal dose (tissue metal levels) constitute the 
necessary next step of the studies. In case of oral application of the metals in aqueous 
solution, the effects were of similar kind and magnitude as seen earlier. It was known 
from the preceding intratracheal NP exposures that in this form much lower per kg 
doses are sufficient in terms of internal dose and functional effects. Comparison of the 
results from the present study to those mentioned above indicated that a lower NP 
dose was enough to evoke the same effects when applied after oral treatment. 
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